<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30283335</article-id>
<article-id pub-id-type="pmc">6156278</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2018.01008</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Development of an AmpliSeq<sup>TM</sup> Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kringel</surname>
<given-names>Dario</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/442201/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaunisto</surname>
<given-names>Mari A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/607222/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lippmann</surname>
<given-names>Catharina</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/442184/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalso</surname>
<given-names>Eija</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/446166/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lötsch</surname>
<given-names>Jörn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/428143/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institute of Clinical Pharmacology, Goethe-University</institution>, <addr-line>Frankfurt</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki</institution>, <addr-line>Helsinki</addr-line>, <country>Finland</country></aff>
<aff id="aff3"><sup>3</sup><institution>Fraunhofer Institute for Molecular Biology and Applied Ecology – Project Group Translational Medicine and Pharmacology</institution>, <addr-line>Frankfurt</addr-line>, <country>Germany</country></aff>
<aff id="aff4"><sup>4</sup><institution>Division of Pain Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital</institution>, <addr-line>Helsinki</addr-line>, <country>Finland</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ulrich M. Zanger, Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie (IKP), Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Theodora Katsila, University of Patras, Greece; Cheryl D. Cropp, Samford University, United States</p>
</fn>
<corresp id="c001">*Correspondence: Jörn Lötsch, <email>j.loetsch@em.uni-frankfurt.de</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Pharmacogenetics and Pharmacogenomics, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>1008</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Kringel, Kaunisto, Lippmann, Kalso and Lötsch.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Kringel, Kaunisto, Lippmann, Kalso and Lötsch</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p><bold>Background:</bold> Many gene variants modulate the individual perception of pain and possibly also its persistence. The limited selection of single functional variants is increasingly being replaced by analyses of the full coding and regulatory sequences of pain-relevant genes accessible by means of next generation sequencing (NGS).</p>
<p><bold>Methods:</bold> An NGS panel was created for a set of 77 human genes selected following different lines of evidence supporting their role in persisting pain. To address the role of these candidate genes, we established a sequencing assay based on a custom AmpliSeq<sup>TM</sup> panel to assess the exomic sequences in 72 subjects of Caucasian ethnicity. To identify the systems biology of the genes, the biological functions associated with these genes were assessed by means of a computational over-representation analysis.</p>
<p><bold>Results:</bold> Sequencing generated a median of 2.85 ⋅ 10<sup>6</sup> reads per run with a mean depth close to 200 reads, mean read length of 205 called bases and an average chip loading of 71%. A total of 3,185 genetic variants were called. A computational functional genomics analysis indicated that the proposed NGS gene panel covers biological processes identified previously as characterizing the functional genomics of persisting pain.</p>
<p><bold>Conclusion:</bold> Results of the NGS assay suggested that the produced nucleotide sequences are comparable to those earned with the classical Sanger sequencing technique. The assay is applicable for small to large-scale experimental setups to target the accessing of information about any nucleotide within the addressed genes in a study cohort.</p>
</abstract>
<kwd-group>
<kwd>pain</kwd>
<kwd>data science</kwd>
<kwd>knowledge discovery</kwd>
<kwd>functional genomics</kwd>
<kwd>next generation sequencing (NGS)</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Seventh Framework Programme<named-content content-type="fundref-id">10.13039/100011102</named-content></funding-source>
<award-id rid="cn001">602919</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="254"></ref-count>
<page-count count="22"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Persisting pain has been proposed to result from a gene environment interaction where nerve injuries or inflammatory processes act as triggers while the clinical symptoms develop only in a minority of subjects (<xref ref-type="bibr" rid="B125">Lee and Tracey, 2013</xref>). A role of the genetic background in pain is supported by evidence of many variants modulating the individual perception of pain and the development of its persistence (<xref ref-type="bibr" rid="B42">Diatchenko et al., 2005</xref>; <xref ref-type="bibr" rid="B139">Lötsch et al., 2009b</xref>; <xref ref-type="bibr" rid="B161">Mogil, 2012</xref>). Genetic variants have been reported to confer protection against pain such as the rs1799971 variant in the μ-opioid receptor gene (<italic>OPRM1</italic>) (<xref ref-type="bibr" rid="B146">Lötsch et al., 2006</xref>), or to increase the risk for persisting pain such as the rs12584920 variant of the 5-hydroxytryptamine receptor 2A gene (<italic>HTR2A</italic>) (<xref ref-type="bibr" rid="B166">Nicholl et al., 2011</xref>) or the rs734784 polymorphism in the voltage-gated potassium ion channel modifier, subfamily S member 1, gene (<italic>KCNS1</italic>) (<xref ref-type="bibr" rid="B34">Costigan et al., 2010</xref>). Nevertheless, the genetic background of persisting pain is still incompletely understood (<xref ref-type="bibr" rid="B160">Mogil, 2009</xref>; <xref ref-type="bibr" rid="B142">Lötsch and Geisslinger, 2010</xref>) and under intense discussion.</p>
<p>Until recently, research focused on the role of selected functional genetic variants as protective or risk factors of persisting pain. This has changed with the broader availability of next generation sequencing (NGS) (<xref ref-type="bibr" rid="B155">Metzker, 2010</xref>). To make use of these technical advancements, we developed a custom AmpliSeq<sup>TM</sup> library and sequencing assay for efficient detection of genetic variants possibly associated with persisting pain. We propose an assay of a set of 77 genes supported by evidence of an involvement in pain and its development toward persistence. The set size fully uses the technical specifications of the AmpliSeq<sup>TM</sup> gene sequencing library technique.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Selection of Genes Relevant for Persisting Pain</title>
<p>A set of candidate genes with shown or biologically plausible relevance to persisting pain was created by applying a combination of criteria, which provided three different genetic subsets. <bold>Subset 1</bold> was chosen exclusively on the basis of computational functional genomics based on a recently published analysis of persisting pain regarded as displaying systemic features of learning and neuronal plasticity (<xref ref-type="bibr" rid="B149">Mansour et al., 2014</xref>). As discussed previously (<xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>), the view of chronic pain as a dysregulation in biological processes of learning and neuronal plasticity (<xref ref-type="bibr" rid="B4">Alvarado et al., 2013</xref>) seems to be captured by the controlled vocabulary (<xref ref-type="bibr" rid="B19">Camon et al., 2004</xref>) of the Gene Ontology (GO) knowledge base by the GO terms “learning or memory” (GO:0007611)<sup><xref ref-type="fn" rid="fn01">1</xref></sup> and “nervous system development” (GO:0007399)<sup><xref ref-type="fn" rid="fn02">2</xref></sup>. An intersection of the genes annotated to these GO terms with a set of 539 “pain genes” identified empirically as relevant to pain provided the first subset of 34 genes described in detail previously (<xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>). Briefly, the intersecting set of so-called “pain genes” consists of a combination of (i) genes listed in the PainGenes database (<xref ref-type="bibr" rid="B121">Lacroix-Fralish et al., 2007</xref>)<sup><xref ref-type="fn" rid="fn03">3</xref></sup>, (ii) genes causally involved in human hereditary diseases associated with extreme pain phenotypes, (iii) genes found to be associated with chronic pain in at least three human studies, and (iv) genes coding for targets of novel analgesics under clinical development (<xref ref-type="bibr" rid="B137">Lötsch et al., 2013</xref>).</p>
<p><bold>Subset 2</bold> consisted of genes that were reported to carry variants modulating the risk or the phenotypic symptoms in at least two different clinical settings of persisting pain. They were obtained using (i) a PubMed database search for the string “(chronic OR persisting OR neuropathic OR back OR inflammatory OR musculoskeletal OR visceral OR widespread OR idiopathic OR fibromyalgia) AND pain AND (polymorphism OR variant) NOT review,” to which genes highlighted in overviews on pain genetics (e.g., <xref ref-type="bibr" rid="B53">Edwards, 2006</xref>) were added. The intersection of the queried genes with the set of 539 “pain genes” (see above) provided a subset of 13 genes (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Genes included in the proposed NGS panel of persisting pain, combined from three subsets included on different bases.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene symbol</th>
<th align="left" colspan="1" rowspan="1" valign="top">NCBI</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene description</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="4" rowspan="1" valign="top">
<bold>Subset #1</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADCY1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">107</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adenylate cyclase 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B234">Vadakkan et al., 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BDNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">627</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brain-derived neurotrophic factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B169">Obata and Noguchi, 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CDK5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1020</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cyclin-dependent kinase 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B248">Yang et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CHRNB2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1141</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cholinergic receptor, nicotinic, beta 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B44">Dineley et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1268</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cannabinoid receptor 1 (brain)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B214">Smith et al., 1998</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DLG4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1742</td>
<td align="left" colspan="1" rowspan="1" valign="top">Disks, large homolog 4 (Drosophila)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B60">Florio et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1812</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B174">Onojjighofia et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1813</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B174">Onojjighofia et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1814</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B182">Potvin et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>EGR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1958</td>
<td align="left" colspan="1" rowspan="1" valign="top">Early growth response 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B113">Ko et al., 2005</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FOS</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2353</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cellular oncogene FOS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B1">Abbadie et al., 1994</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FYN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2534</td>
<td align="left" colspan="1" rowspan="1" valign="top">Src family tyrosine kinase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B133">Liu et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GABRA5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2558</td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA A receptor, alpha 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B13">Bravo-Hernández et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GALR2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8811</td>
<td align="left" colspan="1" rowspan="1" valign="top">Galanin receptor 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B93">Hulse et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2902</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate receptor, NMDA 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B180">Petrenko et al., 2003</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2903</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate receptor, NMDA 2A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B180">Petrenko et al., 2003</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN2B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2904</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate receptor, NMDA 2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B180">Petrenko et al., 2003</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRM5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2915</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate receptor, metabotropic 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B238">Walker et al., 2001</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HRH3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11255</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histamine receptor H3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B92">Huang et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KIT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3815</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tyrosine kinase KIT</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B223">Sun et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4763</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurofibromin 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B245">Wolters et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NGF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4803</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nerve growth factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B118">Kumar and Mahal, 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NTF4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4909</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotrophin 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B118">Kumar and Mahal, 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NTRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4914</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotrophic tyrosine kinase 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B118">Kumar and Mahal, 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OXT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5020</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oxytocin prepropeptide</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B73">Goodin et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PLCB1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">23236</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phospholipase C, beta 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B208">Shi T.-J.S. et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PRKCG</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5582</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein kinase C, gamma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B213">Sluka and Audette, 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PRNP</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5621</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prion protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B64">Gadotti and Zamponi, 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5764</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pleiotrophin</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B75">Gramage and Herradon, 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTPRZ1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5803</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein tyrosine phosphatase Z 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RELN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5649</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reelin</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B15">Buchheit et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>S100B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6285</td>
<td align="left" colspan="1" rowspan="1" valign="top">S100 calcium binding protein B</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B251">Zanette et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SLC6A4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6532</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serotonin transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B172">Offenbaecher et al., 1999</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7054</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tyrosine hydroxylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B12">Bravo et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1" valign="top">
<bold>Subset #2</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADRB2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">154</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adrenoceptor beta 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B87">Hocking et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>COMT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1312</td>
<td align="left" colspan="1" rowspan="1" valign="top">Catechol-<italic>O</italic>-methyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B58">Feng et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2099</td>
<td align="left" colspan="1" rowspan="1" valign="top">Extrogen Receptor 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B188">Ribeiro-Dasilva et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GCH1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2643</td>
<td align="left" colspan="1" rowspan="1" valign="top">GTP cyclohydrolase 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B224">Tegeder et al., 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL1B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3553</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interleukin 1B</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B136">Loncar et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3565</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interleukin 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B222">Sugaya et al., 2002</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3569</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interleukin 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B209">Shoskes et al., 2002</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL10</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3586</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interleukin 10</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B221">Stephens et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>P2RX7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5027</td>
<td align="left" colspan="1" rowspan="1" valign="top">Purinergic Receptor P2X7</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B220">Sorge et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCN9A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6335</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sodium voltage-gated alpha subunit 9</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B186">Reimann et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6648</td>
<td align="left" colspan="1" rowspan="1" valign="top">Superoxide dismutase 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B202">Schwartz et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7124</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tumor necrosis factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B126">Leung and Cahill, 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7442</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transient receptor potential cation channel, subfamily V, member 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B11">Bourinet et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1" valign="top">
<bold>Subset #3</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABHD12</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">26090</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abhydrolase domain containing 12</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B109">Kim, 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABHD16A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7920</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abhydrolase domain containing 16A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B109">Kim, 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABHD6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">57406</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abhydrolase domain containing 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B109">Kim, 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CACNG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">10369</td>
<td align="left" colspan="1" rowspan="1" valign="top">Calcium voltage-gated channel auxiliary subunit gamma 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B167">Nissenbaum et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CSF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1435</td>
<td align="left" colspan="1" rowspan="1" valign="top">Colony stimulating factor 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B225">Thuault, 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1815</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B16">Buskila et al., 2004</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FAAH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2166</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fatty acid amide hydrolase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B99">Jayamanne et al., 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FKBP5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2289</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fk506 binding protein 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B63">Fujii et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GDNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2668</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glial cell derived neurotrophic factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B191">Sah et al., 2005</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GFRA1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2674</td>
<td align="left" colspan="1" rowspan="1" valign="top">GDNF family receptor alpha 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B247">Yamamoto et al., 2003</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GPR132</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">29933</td>
<td align="left" colspan="1" rowspan="1" valign="top">G protein-coupled receptor 132</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B89">Hohmann et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HCN2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">610</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperpolarization-activated cyclic nucleotide-gated</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B229">Tsantoulas et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HLA-DQB1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3119</td>
<td align="left" colspan="1" rowspan="1" valign="top">Major histocompatibility complex, class II, DQ beta 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B48">Dominguez et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HLA-DRB1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3123</td>
<td align="left" colspan="1" rowspan="1" valign="top">Major histocompatibility complex, class II, DR beta 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B48">Dominguez et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR1A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3350</td>
<td align="left" colspan="1" rowspan="1" valign="top">5-hydroxytryptamine (serotonin) receptor 1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B130">Lindstedt et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3356</td>
<td align="left" colspan="1" rowspan="1" valign="top">5-hydroxytryptamine (serotonin) receptor 2A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B166">Nicholl et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL1R2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7850</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interleukin 1 receptor type 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B221">Stephens et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KCNS1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3787</td>
<td align="left" colspan="1" rowspan="1" valign="top">Potassium voltage-gated channel, modifier subfamily S, member 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B34">Costigan et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LTB4R</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1241</td>
<td align="left" colspan="1" rowspan="1" valign="top">Leukotriene b4 receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B253">Zinn et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LTB4R2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">56413</td>
<td align="left" colspan="1" rowspan="1" valign="top">Leukotriene b4 receptor 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B253">Zinn et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRD1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4985</td>
<td align="left" colspan="1" rowspan="1" valign="top">Opioid receptor delta 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B123">Law et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4986</td>
<td align="left" colspan="1" rowspan="1" valign="top">Opioid receptor kappa 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B77">Guerrero et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4988</td>
<td align="left" colspan="1" rowspan="1" valign="top">Opioid receptor mu 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B141">Lötsch and Geisslinger, 2005</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RET</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5979</td>
<td align="left" colspan="1" rowspan="1" valign="top">RET receptor tyrosine kinase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B215">Snider and McMahon, 1998</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RUNX1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">861</td>
<td align="left" colspan="1" rowspan="1" valign="top">Runt related transcription factor 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B24">Chen et al., 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TLR4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7099</td>
<td align="left" colspan="1" rowspan="1" valign="top">Toll like Receptor 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B94">Hutchinson et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPA1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8989</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transient receptor potential cation channel, subfamily A, member 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B11">Bourinet et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPM8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">79054</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transient receptor potential cation channel, subfamily M, member 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B11">Bourinet et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">59341</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transient receptor potential cation channel, subfamily V, member 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B11">Bourinet et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TSPO</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">706</td>
<td align="left" colspan="1" rowspan="1" valign="top">Translocator protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B134">Loggia et al., 2015</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Subset #1 comprises <italic>d</italic> = 34 genes that had resulted from a computational functional genomics analysis (<xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>) pursuing the hypothesis that persisting pain displays systemic features of learning and neuronal plasticity (<xref ref-type="bibr" rid="B149">Mansour et al., 2014</xref>). Hence, from a set of genes identified empirically as relevant to pain and listed in the PainGenes database (<ext-link ext-link-type="uri" xlink:href="http://www.jbldesign.com/jmogil/enter.html">http://www.jbldesign.com/jmogil/enter.html</ext-link>, <xref ref-type="bibr" rid="B121">Lacroix-Fralish et al., 2007</xref>), those were selected that are annotated to the Gene Ontology (<xref ref-type="bibr" rid="B6">Ashburner et al., 2000</xref>) terms “learning or memory” and “nervous system development.” The references are those found to provide evidence for an association with pain, except for PTPRZ1 that was a novel finding in (<xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>). Subset #2 comprises <italic>d</italic> = 13 genes identified empirically as relevant to pain and listed in the PainGenes database (<ext-link ext-link-type="uri" xlink:href="http://www.jbldesign.com/jmogil/enter.html">http://www.jbldesign.com/jmogil/enter.html</ext-link>, <xref ref-type="bibr" rid="B121">Lacroix-Fralish et al., 2007</xref>) and reported to carry variants that modulated the risk or the symptomatology in at least two different clinical settings of persisting paint. Subset #3 comprises <italic>d</italic> = 30 genes repeatedly shown during the last several years to play a role in the human genetics of persisting pain or recently reported as novel players.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>Finally, <bold>subset 3</bold> comprised genes that have consistently been included in human pain research projects over the last several years. One of them is the <italic>OPRM1</italic> gene that codes for the human μ-opioid receptor and which has been shown to modulate the time course of persisting cancer pain by delaying the necessity of opioid treatment (<xref ref-type="bibr" rid="B143">Lötsch et al., 2010</xref>). However, further genes were added such as the <italic>GDNF</italic> gene coding for the glial cell derived neurotrophic factor, which has been shown to be involved in a glia-dependent mechanism of neuropathic pain (<xref ref-type="bibr" rid="B240">Wang et al., 2014</xref>) although no modulating human genetic variants have been reported so far. Following expert counseling within the EU-funded “glial-opioid interface in chronic pain, GLORIA” research consortium (<xref ref-type="bibr" rid="B115">Kringel and Lötsch, 2015</xref>)<sup><xref ref-type="fn" rid="fn04">4</xref></sup>, a subset of 30 genes (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>) was identified. Thus, the complete set as the union of the three subsets comprised 43 + 13 + 30 = 77 genes that are proposed to be included in an NGS panel of human persisting pain.</p>
</sec>
<sec>
<title>DNA Sample Origin</title>
<p>Due to the costs of assay development (for details, see second paragraph of the Discussion), the Ampliseq<sup>TM</sup> panel was established in a limited number of <italic>n</italic> = 72 DNA samples. This corresponds to the number of samples used in comparable recent studies for NGS assay establishment and validation (<xref ref-type="bibr" rid="B14">Bruera et al., 2018</xref>; <xref ref-type="bibr" rid="B38">De Luca et al., 2018</xref>; <xref ref-type="bibr" rid="B162">Mustafa et al., 2018</xref>; <xref ref-type="bibr" rid="B205">Shah et al., 2018</xref>). To further limit the project costs, the Ampliseq<sup>TM</sup> panel was established in a subset of samples originating from a clinical cohort of 1,000 women who had undergone breast cancer surgery (<xref ref-type="bibr" rid="B104">Kaunisto et al., 2013</xref>; <xref ref-type="bibr" rid="B144">Lötsch et al., 2018</xref>). The study followed the Declaration of Helsinki and was approved by the Coordinating Ethics Committee of the Helsinki University Hospital. Each participating subject had provided a written informed consent including genetic studies.</p>
<p>Specifically, for the presently reported method establishment, a subsample of 72 women (age 58.4 ± 8 years, mean ± standard deviation, weight 69.3 ± 11 kg), was drawn from the clinical subgroup not having developed persisting pain during the observation period. This was believed to come closer to a random sample than a mixture of patients with persisting and without persisting pain. This limitation of the sample selection has probably affected which and how many variants were identified. However, it is unlikely to have jeopardized the general applicability of the gene selection heuristics, assay establishment and validation, and of the functional analysis of the selected subset of genes.</p>
</sec>
<sec>
<title>DNA Template Preparation and Amplification</title>
<p>A multiplex PCR amplification strategy for the coding gene sequences was accomplished online (Ion Ampliseq<sup>TM</sup> Designer)<sup><xref ref-type="fn" rid="fn05">5</xref></sup> to amplify the target region specified above (for primer sequences, see <bold>Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref></bold>) with 25 base pair exon padding. After a comparison of several primer design options, the design providing the maximum target sequence coverage was chosen. The ordered 1,953 amplicons covered approximately 97.5% of the target sequence (<bold>Supplementary Table <xref ref-type="supplementary-material" rid="SM2">2</xref></bold>). A total of 10 ng DNA per sample was used for the target enrichment by a multiplex PCR and each DNA pool was amplified with the Ion Ampliseq<sup>TM</sup> Library Kit in conjunction with the Ion Ampliseq<sup>TM</sup> “custom Primer Pool”-protocols according to the manufacturer’s procedures (Life Technologies, Darmstadt, Germany).</p>
<p>After each pool had undergone 18 PCR cycles, the PCR primers were removed with FuPa Reagent and the amplicons were ligated to the sequencing adaptors with short stretches of index sequences (barcodes) that enabled sample multiplexing for subsequent steps (Ion Xpress<sup>TM</sup> Barcode Adapters Kit; Life Technologies). After purification with AMPure XP beads (Beckman Coulter, Krefeld, Germany), the barcoded libraries were quantified with a Qubit<sup>®</sup> 2.0 Fluorimeter (Life Technologies, Darmstadt, Germany) and normalized for DNA concentration to a final concentration of 20 pmol/l using the Ion Library Equalizer<sup>TM</sup> Kit (Life Technologies, Darmstadt, Germany). Equalized barcoded libraries from seven to eight samples at a time were pooled. To clonally amplify the library DNA onto the Ion Sphere Particles (ISPs; Life Technologies, Darmstadt, Germany), the library pool was subjected to emulsion PCR by using an Ion PGM HI-Q View Template Kit on an PGM OneTouch system (Life Technologies, Darmstadt, Germany) following the manufacturer’s protocol.</p>
</sec>
<sec>
<title>Sequencing</title>
<p>Enriched ISPs which carried many copies of the same DNA fragment were subjected to sequencing on an Ion 318 Chip to sequence pooled libraries with seven to eight samples. During this process, bases are inferred from light intensity signals, a process commonly referred to as base-calling (<xref ref-type="bibr" rid="B124">Ledergerber and Dessimoz, 2011</xref>). The number of combined libraries that can be accommodated in a single sequencing run depends on the size of the chip, the balance of barcoded library concentration, and the coverage required. The high-capacity 318 chip was chosen (instead of the low-capacity 314 or the medium-capacity 316 chip) to obtain a high sequencing depth of coverage for a genomic DNA library with &gt;95% of bases at 30x. Sequencing was performed using the sequencing kit (Ion PGM Hi-Q Sequencing Kit; Life Technologies, Darmstadt, Germany) as per the manufacturer’s instructions with the 200 bp single-end run configuration. This kit contained the most advanced sequencing chemistry available to users of the Ion PGM System (Life Technologies, Darmstadt, Germany).</p>
</sec>
<sec>
<title>Data Analysis</title>
<sec>
<title>Bioinformatics Generation of Sequence Information</title>
<p>The raw data (unmapped BAM-files) from the sequencing runs were processed using Torrent Suite Software (Version 5.2.2, Life Technologies, Darmstadt, Germany) to generate read alignments which were filtered by the software into mapped BAM-files using the reference genomic sequence (hg19) of target genes. Variant calling was performed with the Torrent Variant Caller Plugin using as key parameters: minimum allele frequency = 0.15, minimum quality = 10, minimum coverage = 20 and minimum coverage on either strand = 3.</p>
<p>The annotation of called variants was done using the Ion Reporter Software (Version 4.4; Life Technologies, Darmstadt, Germany) for the VCF files that contained the nucleotide reads and the GenomeBrowse<sup>®</sup> software (Version 2.0.4, Golden Helix, Bozeman, MT, United States) to map the sequences to the reference sequences GRCh37 hg19 (dated February 2009). The SNP and Variation Suite software (Version 8.4.4; Golden Helix, Bozeman, MT, United States) was used for the analysis of sequence quality, coverage and for variant identification.</p>
<p>Based on the observed allelic frequency, the expected number of homozygous and heterozygous carriers of the respective SNP (single nucleotide polymorphism) was calculated using the Hardy-Weinberg equation. Only variants within the Hardy-Weinberg equilibrium as assessed using Fisher’s exact test (<xref ref-type="bibr" rid="B54">Emigh, 1980</xref>) were retained. The SNP and Variation Suite software (Version 8.4.4; Golden Helix, Bozeman, MT, United States) was used for the analysis of sequence quality, coverage and for variant identification.</p>
</sec>
</sec>
<sec>
<title>Assay Validation</title>
<p>Method validation was accomplished by means of Sanger sequencing (<xref ref-type="bibr" rid="B192">Sanger and Coulson, 1975</xref>; <xref ref-type="bibr" rid="B193">Sanger et al., 1977</xref>) in an independent external laboratory (Eurofins Genomics, Ebersberg, Germany). As performed previously with different AmpliSeq<sup>TM</sup> panels (<xref ref-type="bibr" rid="B116">Kringel et al., 2017</xref>) and other genotyping assays (<xref ref-type="bibr" rid="B211">Skarke et al., 2004</xref>, <xref ref-type="bibr" rid="B212">2005</xref>), four DNA samples have been chosen randomly from an independent cohort of healthy subjects and sequenced with the current NGS panel. For the detected variant type, single nucleotide polymorphisms from five different genomic regions for which clinical associations have been reported (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>), i.e., rs324420 (<italic>FAAH</italic>), rs333970 (<italic>CSF1</italic>), rs4986790 (<italic>TLR4)</italic>, rs4633 (<italic>COMT</italic>), and rs17151558 (<italic>RELN</italic>) were chosen for external sequencing. Amplification of the respective DNA segments was done using PCR primer pairs (forward, reverse) of (i) 5′-TTTCTTAAAAAGGCCAGCCTCCT-3′ and 5′-AATGACCCAAGATGCAGAGCA-3′ (ii) 5′-GCCTTCAACCCCGGGATGG-3′ and 5′-CTCCGATCCCTGGTGCTCCTC-3′ (iii) 5′-TTTATTGCACAGACTTGCGGGTTC-3′ and 5′-AGCCTTTTGAGAGATTTGAGTTTCA-3′ (iv) 5′-CCTTATCGGCTGGAACGAGTT-3′ and 5′-GTAAGGGCTTTGATGCCTGGT-3′ (v) 5′-GTTATTCCTCTGTAAGCAGCTGCCT-3′ and 5′-TGTTTGTTTTAGATTGTGGTGGGTT-3′. Results of Sanger sequencing were aligned with the genomic sequence and analyzed using Chromas Lite<sup>®</sup> (Version 2.1.1, Technelysium Pty Ltd, South Brisbane, QLD, Australia) and the GenomeBrowse<sup>®</sup> (Version 2.0.4, Golden Helix, Bozeman, MT, United States) was used to compare the sequences obtained with NGS or Sanger techniques.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>A list of coding human variants in the 77 putative chronic pain genes, found in the present random sample of 72 subjects of Caucasian ethnicity, for which clinical associations have been reported.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Variant</th>
<th align="left" colspan="1" rowspan="1" valign="top">dbSNP<sup>#</sup> accession number</th>
<th align="left" colspan="1" rowspan="1" valign="top">Known clinical association</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Pain context</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FAAH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:46870761-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs324420</td>
<td align="left" colspan="1" rowspan="1" valign="top">Effect of endocannabinoid degradation on pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B17">Cajanus et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FAAH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:46870761-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs324420</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cold and heat pain sensitivity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B107">Kim et al., 2006b</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CSF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:110466338-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs333970</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheumatoid arthritis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B216">Solus et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NGF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:115829313-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6330</td>
<td align="left" colspan="1" rowspan="1" valign="top">Procedural pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B55">Ersig et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NGF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:115829313-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6330</td>
<td align="left" colspan="1" rowspan="1" valign="top">Susceptibility to migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B33">Coskun et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL1B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:113590966-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1143634</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adverse effects in postoperative pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B218">Somogyi et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL1B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:113590966-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1143634</td>
<td align="left" colspan="1" rowspan="1" valign="top">Low back pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B57">Feng et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCN9A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:167099158-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6746030</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pain susceptibility in Parkinson disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B76">Greenbaum et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCN9A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:167099158-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6746030</td>
<td align="left" colspan="1" rowspan="1" valign="top">Congenital insensitivity to pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B111">Klein et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCN9A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:167099158-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6746030</td>
<td align="left" colspan="1" rowspan="1" valign="top">Basal Pain Sensitivity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B49">Duan et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCN9A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:167145122-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs188798505</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered pain perception</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B186">Reimann et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3:113890815-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6280</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acute pain in sickle cell disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B100">Jhun et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3:113890815-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6280</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher prevalence of migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B91">Hu et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADRB2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5:148206646-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1042717</td>
<td align="left" colspan="1" rowspan="1" valign="top">Musculoskeletal pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B41">Diatchenko et al., 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADRB2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5:148206885-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1800888</td>
<td align="left" colspan="1" rowspan="1" valign="top">Migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B199">Schurks et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:152129077-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2077647</td>
<td align="left" colspan="1" rowspan="1" valign="top">Migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B200">Schürks et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:152129077-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2077647</td>
<td align="left" colspan="1" rowspan="1" valign="top">Musculoskeletal pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B244">Wise et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:154360797-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1799971</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pain of various origins</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B140">Lötsch et al., 2009c</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:160113872-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4880</td>
<td align="left" colspan="1" rowspan="1" valign="top">Migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B176">Palmirotta et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7:22771039-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs13306435</td>
<td align="left" colspan="1" rowspan="1" valign="top">Low back pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B56">Eskola et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8:54142157-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs702764</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuropathic pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B66">Garassino et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TLR4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9:120475302-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4986790</td>
<td align="left" colspan="1" rowspan="1" valign="top">Musculoskeletal pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B68">Gbbbebura et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:2188238-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6357</td>
<td align="left" colspan="1" rowspan="1" valign="top">Widespread Pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B101">Jhun et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:2190951-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6356</td>
<td align="left" colspan="1" rowspan="1" valign="top">Migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B32">Corominas et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BDNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:27679916-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6265</td>
<td align="left" colspan="1" rowspan="1" valign="top">Widespread Pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B55">Ersig et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:113283459-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6277</td>
<td align="left" colspan="1" rowspan="1" valign="top">Post-surgical pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B106">Kim et al., 2006a</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:113283477-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6275</td>
<td align="left" colspan="1" rowspan="1" valign="top">Migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B173">Onaya et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>P2RX7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">12:121600253-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs208294</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cold pain sensitivity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B96">Ide et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>P2RX7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">12:121605355-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs7958311</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuropathic pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B232">Ursu et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">13:47409034-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6314</td>
<td align="left" colspan="1" rowspan="1" valign="top">Migraine susceptibility</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B249">Yücel et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">17:3480447-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs8065080</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuropathic pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B47">Doehring et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KCNS1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">20:43723627-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs734784</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuropathic pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B47">Doehring et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">COMT</td>
<td align="left" colspan="1" rowspan="1" valign="top">22:19950235-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4633</td>
<td align="left" colspan="1" rowspan="1" valign="top">Postoperative pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B105">Khalil et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>COMT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">22:19950263-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6267</td>
<td align="left" colspan="1" rowspan="1" valign="top">Widespread Pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B129">Lin et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>COMT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">22:19951271-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4680</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered pain perception</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B241">Wang et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<bold>Other context</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CSF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:110466466-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1058885</td>
<td align="left" colspan="1" rowspan="1" valign="top">Periodontitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B25">Chen et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CSF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:110466555-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2229165</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carcinogenesis/breast cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B195">Savas et al., 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NTRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:156846233-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6334</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nephropathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B81">Hahn et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NTRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">1:156848946-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6339</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acute myeloid leukemia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B203">Schweinhardt et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCN9A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:167143050-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs41268673</td>
<td align="left" colspan="1" rowspan="1" valign="top">Erythromelalgia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B111">Klein et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPM8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:234854550-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11562975</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperresponsiveness in bronchial asthma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B164">Naumov et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPM8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2:234905078-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11563208</td>
<td align="left" colspan="1" rowspan="1" valign="top">Anthropometric parameters</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B181">Potapova et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3:113890789-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3732783</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phenotypic traits relevant to anorexia nervosa</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B190">Root et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KIT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4:55593464-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3822214</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cancer risk</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B179">Pelletier and Weidhaas, 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KIT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4:55602765-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3733542</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glandular odontogenic cyst</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B210">Siqueira et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR1A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5:63257483-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1799921</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bipolar disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B74">Goodyer et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADRB2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5:148206646-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1042717</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cognitive dysfunction in opioid-treated patients with cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B119">Kurita et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5:174868840-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs155417</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alcohol dependence</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B78">Hack et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HLA-DQB1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:32629920-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs41544112</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ulcerative colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B2">Achkar et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FKBP5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:35544942-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs34866878</td>
<td align="left" colspan="1" rowspan="1" valign="top">Clinical response in pediatric acute myeloid leukemia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B158">Mitra et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:88853635-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1049353</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bone mineral density</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B246">Woo et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:88853635-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1049353</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alcohol dependence</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B150">Marcos et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:88853635-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1049353</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nicotine dependence</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B27">Chen et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:88853635-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1049353</td>
<td align="left" colspan="1" rowspan="1" valign="top">Obesity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B196">Schleinitz et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:88853635-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1049353</td>
<td align="left" colspan="1" rowspan="1" valign="top">Psychiatric disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B85">Hillard et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:152129077-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2077647</td>
<td align="left" colspan="1" rowspan="1" valign="top">Breast cancer susceptibility</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B128">Li et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:152129077-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2077647</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prostate cancer development</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B102">Jurečeková et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:152129077-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2077647</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteoporosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B219">Sonoda et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:152129308-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs746432</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mood disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B156">Mill et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:152201875-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4986934</td>
<td align="left" colspan="1" rowspan="1" valign="top">Endometrial cancer risk</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B242">Wedrén et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:154360508-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6912029</td>
<td align="left" colspan="1" rowspan="1" valign="top">Irritable bowel syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B18">Camilleri et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:154360797-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1799971</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B204">Serý et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:154414573-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs562859</td>
<td align="left" colspan="1" rowspan="1" valign="top">Depressive disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B67">Garriock et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:154414563-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs675026</td>
<td align="left" colspan="1" rowspan="1" valign="top">Treatment response for opiate dependence</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B3">Al-Eitan et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:160113872-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4880</td>
<td align="left" colspan="1" rowspan="1" valign="top">Development of type 2 diabetes mellitus</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B127">Li et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:160113872-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4880</td>
<td align="left" colspan="1" rowspan="1" valign="top">Breast cancer susceptibility</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B189">Rodrigues et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6:160113872-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4880</td>
<td align="left" colspan="1" rowspan="1" valign="top">Asthma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B250">Yucesoy et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADCY1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7:45703971-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1042009</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bipolar disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B207">Shi J. et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RELN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7:103124207-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1062831</td>
<td align="left" colspan="1" rowspan="1" valign="top">Attention deficit hyperactivity disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B120">Kwon et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RELN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7:103251161-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs362691</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B51">Dutta et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8:54142154-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs16918875</td>
<td align="left" colspan="1" rowspan="1" valign="top">Susceptibility to addiction</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B117">Kumar et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8:72948588-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs13280644</td>
<td align="left" colspan="1" rowspan="1" valign="top">Perception olfactory stimuli</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B201">Schütz et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TLR4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9:120475602-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4986791</td>
<td align="left" colspan="1" rowspan="1" valign="top">Breast cancer susceptibility</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B157">Milne et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9:140051238-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6293</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B70">Georgi et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RET</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">10:43610119-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1799939</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hirschsprung’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B233">Vaclavikova et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RET</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">10:43615094-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1800862</td>
<td align="left" colspan="1" rowspan="1" valign="top">Medullary thyroid carcinoma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B22">Ceolin et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GFRA1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">10:117884950-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2245020</td>
<td align="left" colspan="1" rowspan="1" valign="top">Age-related macular degeneration</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B197">Schmidt et al., 2006</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:637537-Del</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs587776842</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acousticous neurinoma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B168">Nöthen et al., 1994</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BDNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:27720937-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs66866077</td>
<td align="left" colspan="1" rowspan="1" valign="top">Irritable bowel syndrome-diarrhea</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B18">Camilleri et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11:113283484-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1801028</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurologic disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B46">Doehring et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN2B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">12:13717508-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1806201</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B5">Andreoli et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">12:110252547-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3742030</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyponatremia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B227">Tian et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>P2RX7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">12:121592689-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs17525809</td>
<td align="left" colspan="1" rowspan="1" valign="top">Multiple sclerosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B175">Oyanguren-Desez et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">13:47466622-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6305</td>
<td align="left" colspan="1" rowspan="1" valign="top">Susceptibility to substance abuse</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B84">Herman and Balogh, 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LTB4R</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">14:24785092-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs34645221</td>
<td align="left" colspan="1" rowspan="1" valign="top">Asthma susceptibility</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B230">Tulah et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GABRA5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">15:27182357-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs140682</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism-spectrum disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B88">Hogart et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">16:9943666-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2229193</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperactivity disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B110">Kim et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DLG4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">17:7099811-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs17203281</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B228">Tsai et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SLC6A4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">17:28530193-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6352</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism-spectrum disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B183">Prasad et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">17:29553485-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2285892</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurofibromatosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B148">Maertens et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HCN2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">19:607984-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3752158</td>
<td align="left" colspan="1" rowspan="1" valign="top">Risk of depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B153">McIntosh et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PRKCG</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">19:54394965-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3745396</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteosarcoma susceptibility</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B147">Lu et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PRNP</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">20:4680251-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1799990</td>
<td align="left" colspan="1" rowspan="1" valign="top">Creutzfeldt-Jakob disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B154">Mead et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HRH3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">20:60791422-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3787430</td>
<td align="left" colspan="1" rowspan="1" valign="top">Risk of chronic heart failure</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B83">He et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>S100B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">21:48022230-SNV</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1051169</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B132">Liu et al., 2005</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>The selection is restricted to one or two publications per variant, and it focuses on a pain context corresponding to the main aim of the present NGS gene panel; however, functional variants highlighted in another clinical context are additionally provided in the lower part of the table. <sup>#</sup>Database of Single Nucleotide Polymorphisms (dbSNP). Bethesda (MD, United States): National Center for Biotechnology Information, National Library of Medicine. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link> (<xref ref-type="bibr" rid="B206">Sherry et al., 2001</xref>).</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Results</title>
<p>The NGS assay of the proposed set of 77 human genes relevant to persisting pain was established in 72 genomic DNA samples. As applied previously (<xref ref-type="bibr" rid="B116">Kringel et al., 2017</xref>), only exons including 25 bases of padding around all targeted coding regions for which the realized read-depths for each nucleotide was higher than 20 were contemplated as successfully analyzed. With this acceptance criterion the whole or almost whole coverage of the relevant sequences was obtained (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>; for details on missing variants, see <bold>Supplementary Table <xref ref-type="supplementary-material" rid="SM3">3</xref></bold>). The NGS sequencing process of the whole patient cohort required ten separate runs, each with samples of <italic>n</italic> = 7 or <italic>n</italic> = 8 patients. Coverage statistics were analogous between all runs and matched the scope of accepted quality levels [20–22]. A median of 2.85 ⋅ 10<sup>6</sup> reads per run was produced. The mean depth was close to 200 reads, the mean read length of called bases resulted in 205 bases and average chip loading was 71% (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>). To establish a sequencing output with a high density of ISPs on a sequencing chip, the chip loading value should exceed 60% (Life Technologies, Carlsbad, United States). The generated results of all NGS runs matched with the results obtained with Sanger sequencing of random samples (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>), meaning the accordance of nucleotide sequences between NGS and Sanger sequencing was 100% in all validated samples.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Assay establishment and validation. <bold>(A)</bold> Pseudo-color image of the Ion 318<sup>TM</sup> v2 Chip plate showing percent loading across the physical surface. This sequencing run had a 76% loading, which ensures a high Ion Sphere Particles (ISP) density. Every 318 chip contains 11 million wells and the color scale on the right side conduces as a loading indicator. Deep red coloration stays for a 100% loading, which means that every well in this area contains an ISP (templated and non-templated) whereas deep blue coloration implies that the wells in this area are empty. <bold>(B)</bold> Alignment of a segment of the ion torrent sequence of the <italic>COMT</italic> gene as a Golden Helix Genome Browse<sup>®</sup> readout versus the same sequence according to an externally predicted Sanger electropherogram. Highlighted is the <italic>COMT</italic> variant rs4633 (COMT c.186C&gt;T → p.His62 =) as a heterozygous mutation and a non-mutated wild type. The SNP is part of the functional <italic>COMT</italic> haplotype comprising rs4633, rs4818 and rs4680, which showed &gt;11-fold difference in expressed enzyme activity and was reported to be associated with different phenotypes of pain sensitivity (<xref ref-type="bibr" rid="B42">Diatchenko et al., 2005</xref>).</p>
</caption>
<graphic xlink:href="fphar-09-01008-g001"></graphic>
</fig>
<p>Following elimination of nucleotides agreeing with the standard human genome sequence GRCh37 g1k (dated February 2009), the result of the NGS consisted of a vector of nucleotide information about the <italic>d</italic> = 77 genes for each individual DNA sample (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). This vector had a length equaling the set union of the number of chromosomal positions in which a non-reference nucleotide had been found in any probe of the actual cohort. Specifically, a total of 3,185 genetic variants was found, of which 659 were located in coding parts of the genes, 1,241 were located in introns and 1,285 in the 3′-UTR, 5′-UTR, upstream or downstream regions. The coding variants for which a clinical or phenotypic association have been reported are listed in <bold>Table <xref ref-type="table" rid="T2">2</xref></bold> together with an example of each variant. Most of the observed variants were single nucleotide polymorphisms (<italic>d</italic> = 571) whereas mixed polymorphisms (<italic>d</italic> = 26), nucleotide insertions (<italic>d</italic> = 18) or nucleotide deletions (<italic>d</italic> = 44) were more rarely found.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Mosaic plot representing a contingency table of the types of genetic variants detected by means of the present AmpliSeq<sup>TM</sup> panel versus the genes included in the assay. The vertical size of the cells is proportional to the number of variants of a particular type; the horizontal size of the cells is proportional to the number of variants found in the respective gene. The location of the variants is indicated at the left of the mosaic plot in letters colored similarly to the respective bars in the mosaic plot. Variants were not found at all possible locations of each gene, which causes the reduction of several bars to dashed lines drawn as placeholders and indicating that at the particular location no variant has been found in the respective gene. The figure has been created using the R software package (version 3.4.2 for Linux; <ext-link ext-link-type="uri" xlink:href="http://CRAN.R-project.org/">http://CRAN.R-project.org/</ext-link>, <xref ref-type="bibr" rid="B184">R Development Core Team, 2008</xref>). UTR: untranslated region. NCExonic: Non-coding exonic.</p>
</caption>
<graphic xlink:href="fphar-09-01008-g002"></graphic>
</fig>
</sec>
<sec>
<title>Discussion</title>
<p>In this report, development and validation of a novel Ampliseq<sup>TM</sup> NGS assay for the coding regions and boundary parts of <italic>d</italic> = 77 genes qualifying as candidate modulators of persisting pain is described. The NGS assay produced nucleotide sequences that corresponded, with respect to the selected validation probes, to the results of classical Sanger sequencing. However, the NGS assay substantially reduced the laboratory effort to obtain the genetic information and provides the perquisites to be used in high throughput environments. In particular, the presented NGS assay is convenient for small up to large-scale setups. As mentioned in the methods section, a limitation of the present results applies to the identified genetic variants as only samples from Caucasian women were included. By contrast, the validity of gene selection and assay establishment is unlikely to be reduced by this selection chosen to remain within the financial limits of the present project.</p>
<p>Specifically, as observed previously (<xref ref-type="bibr" rid="B116">Kringel et al., 2017</xref>), the comprehensive genetic information and the high throughput are reflected in the assay costs. Specifically, sequencing of the 77 genes in 72 DNA samples required approximately € 18,000 for the AmpliSeq<sup>TM</sup> custom panel, € 5,500 for library preparation, € 700 for template preparation and € 700 for sequencing. Ten 318 sequencing chips cost around € 7,000 and in addition and basic consumables and laboratory supplies issued approximately € 800. With 7–8 barcoded samples loaded on ten chips, the expense to analyses the gene sequence for a single patient were around € 325. While NGS costs are likely to decrease in the near future (<xref ref-type="bibr" rid="B135">Lohmann and Klein, 2014</xref>), present assay establishment was therefore applied in DNA samples planned for future genotype versus phenotype association analysis, which required using DNA from patients of a pain-relevant cohort instead from a true random sample of healthy subjects.</p>
<p>As a result of the present assay development, a set of <italic>d</italic> = 77 genes was chosen as potentially relevant to persisting pain. The chosen set of genes differs from alternative proposals aiming at similar phenotypes (<xref ref-type="bibr" rid="B161">Mogil, 2012</xref>; <xref ref-type="bibr" rid="B254">Zorina-Lichtenwalter et al., 2016</xref>). However, when analyzing these alternatives for mutual agreement, only limited overlap could be observed (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). This emphasizes that the genetic architecture of persisting pain is incompletely understood, and several independent lines of research can be pursued. Of note, the present set showed the largest agreement with a set of <italic>d</italic> = 539 genes identified empirically as relevant to pain and listed in the PainGenes database (<xref ref-type="bibr" rid="B121">Lacroix-Fralish et al., 2007</xref>)<sup><xref ref-type="fn" rid="fn06">6</xref></sup> or recognized as causing human hereditary diseases associated with extreme pain phenotypes (<xref ref-type="bibr" rid="B137">Lötsch et al., 2013</xref>; <xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>). Combining all proposals into a large panel was not an option due to the technical limitations of the IonTorrent restricting the panel size to 500 kb (pipeline version 5.6.2); therefore, further genes would need to be addressed in separate panels.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Venn diagram (<xref ref-type="bibr" rid="B236">Venn, 1880</xref>) visualizing the intersections between the presently proposed set of human genes involved in modulating the risk or the clinical course of persisting pain (“Current set,” green frame), and two alternative proposals [“Mogil” (<xref ref-type="bibr" rid="B161">Mogil, 2012</xref>), blue frame and “Zorina-Lichtenwalter” (<xref ref-type="bibr" rid="B254">Zorina-Lichtenwalter et al., 2016</xref>), violet frame]. In addition, a set of <italic>d</italic> = 539 genes identified empirically as relevant to pain and either listed in the PainGenes database (<ext-link ext-link-type="uri" xlink:href="http://www.jbldesign.com/jmogil/enter.html">http://www.jbldesign.com/</ext-link><ext-link ext-link-type="uri" xlink:href="http://www.jbldesign.com/jmogil/enter.html">jmogil/enter.html</ext-link>, <xref ref-type="bibr" rid="B121">Lacroix-Fralish et al., 2007</xref>) or added because recognized as causing human hereditary diseases associated with extreme pain phenotypes, found to be regulated in chronic pain in at least three studies including human association studies, or being targets of novel analgesics. The number of shared genes between data sets is numerically shown in the respective intersections of the Venn diagram. The figure has been created using the R software package (version 3.4.2 for Linux; <ext-link ext-link-type="uri" xlink:href="http://CRAN.R-project.org/">http://CRAN.R-project.org/</ext-link>, <xref ref-type="bibr" rid="B184">R Development Core Team, 2008</xref>) with the particular package “Vennerable” (Swinton J., <ext-link ext-link-type="uri" xlink:href="https://r-forge.r-project.org/R/?group_id=474">https://r-forge.r-project.org/R/?group_id=474</ext-link>).</p>
</caption>
<graphic xlink:href="fphar-09-01008-g003"></graphic>
</fig>
<p>In the present study sample, selected with a certain bias by using, as explained above for cost saving, clinical samples from only women and only Caucasians, a total of 659 genetic coding variants were found. Regardless of the sample preselection, 105 clinical associations (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>) could be queried for the observed variants from openly obtainable data sources comprising (i) the Online Mendelian Inheritance in Man (OMIM<sup>®</sup>) database<sup><xref ref-type="fn" rid="fn07">7</xref></sup>, (ii) the NCBI gene index database<sup><xref ref-type="fn" rid="fn08">8</xref></sup>, the GeneCards database<sup><xref ref-type="fn" rid="fn09">9</xref></sup> [27] and the “1000 Genomes Browser”<sup><xref ref-type="fn" rid="fn010">10</xref></sup> (all accessed in December 2017). The observation of functional variants in the present cohort preselected for the absence of pain persistence is plausible as (i) variants can exert protective effects against chronic pain and (ii) most genetic variants identified so far exert only small effects on pain and the individual result of their functional modulations depends on their combined effects or from the sum of positive and negative effects on pain perception (<xref ref-type="bibr" rid="B138">Lötsch et al., 2009a</xref>).</p>
<p>The selection of genes (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>) relied on empirical evidence of their involvement in pain. For subset #1 (<italic>d</italic> = 34), this had been shown for 33 genes in the original paper (<xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>). As the hypothesis that persisting pain displays systemic features of learning and of neuronal plasticity (<xref ref-type="bibr" rid="B149">Mansour et al., 2014</xref>) could be substantiated at a computational functional genomics level, the further gene (<italic>PTPRZ1</italic>, protein tyrosine phosphatase Z 1) can also be regarded as supported by prior knowledge to be included in the present set. The subset comprised, for example, genes associated with the mesolimbic dopaminergic system, i.e., <italic>DRD1, DRD2, DRD3</italic>, which code for dopamine receptors, and <italic>TH</italic>, which is the coding gene for the tyrosine hydroxylase, a metabolic restricting enzyme in dopaminergic pathways, which have been implicated in promoting chronic back pain (<xref ref-type="bibr" rid="B79">Hagelberg et al., 2003</xref>, <xref ref-type="bibr" rid="B80">2004</xref>; <xref ref-type="bibr" rid="B97">Jaaskelainen et al., 2014</xref>; <xref ref-type="bibr" rid="B151">Martikainen et al., 2015</xref>). Further 14 genes were involved in the circadian rhythm recognized as a modulatory factor in various pain conditions such as arthritis (<xref ref-type="bibr" rid="B82">Haus et al., 2012</xref>; <xref ref-type="bibr" rid="B71">Gibbs and Ray, 2013</xref>) and neuropathic pain (<xref ref-type="bibr" rid="B72">Gilron and Ghasemlou, 2014</xref>). The subset further included three NMDA receptor genes (<italic>GRIN1, GRIN2A</italic>, and <italic>GRIN2B</italic>) known to be major players in a number of essential physiological functions including neuroplasticity (<xref ref-type="bibr" rid="B35">Coyle and Tsai, 2004</xref>). In addition, metabotropic glutamate receptors (mGluR) have been implemented in several chronic pain conditions. One subtype, mGluR5, coded by <italic>GRM5</italic>, is of particular interest in the context of pain conditions as recent studies showed a pro-nociceptive role of mGluR5 in models of chronic pain (<xref ref-type="bibr" rid="B238">Walker et al., 2001</xref>; <xref ref-type="bibr" rid="B36">Crock et al., 2012</xref>). Furthermore, genes associated with histaminergic signaling such as <italic>HRH3</italic> have been implicated in pain transmission (<xref ref-type="bibr" rid="B90">Hough and Rice, 2011</xref>) and analgesia (<xref ref-type="bibr" rid="B92">Huang et al., 2007</xref>).</p>
<p>The second subset of genes relied on a new PubMed search rather than on a previously published and hypothesis-based selection of candidate genes. A computational functional genomics analysis of this subset (details not shown) suggested its involvement in (i) immune processes and (ii) nitric oxide signaling. The genes annotated to the GO term “immune system process” included interleukin (IL1B, IL4, IL6, IL10) (<xref ref-type="bibr" rid="B43">Dinarello, 1994</xref>; <xref ref-type="bibr" rid="B28">Choi and Reiser, 1998</xref>; <xref ref-type="bibr" rid="B159">Mocellin et al., 2004</xref>; <xref ref-type="bibr" rid="B165">Nemeth et al., 2004</xref>) and histocompatibility complex related (HLA-B) genes (<xref ref-type="bibr" rid="B50">Dupont and Ceppellini, 1989</xref>), which have been shown to be involved in immunological mechanisms of pain (<xref ref-type="bibr" rid="B194">Sato et al., 2002</xref>; <xref ref-type="bibr" rid="B39">de Rooij et al., 2009</xref>). This is also supported by published evidence for the further genes in this list, such as, <italic>TNF</italic> (<xref ref-type="bibr" rid="B235">Vassalli, 1992</xref>; <xref ref-type="bibr" rid="B61">Franchimont et al., 1999</xref>), <italic>GCH1</italic> (<xref ref-type="bibr" rid="B198">Schott et al., 1993</xref>) and <italic>P2RX7</italic> (<xref ref-type="bibr" rid="B26">Chen and Brosnan, 2006</xref>). The second major process group emerging from the functional genomics analysis of the key evidence for genetic modulation of clinical chronic pain was nitric oxide signaling, in particular metabolic processes, summarized in this context under the GO term “reactive oxygen species metabolic process” which includes the genes <italic>IL6</italic> (<xref ref-type="bibr" rid="B40">Deakin et al., 1995</xref>), <italic>TNF</italic> (<xref ref-type="bibr" rid="B40">Deakin et al., 1995</xref>; <xref ref-type="bibr" rid="B103">Katusic et al., 1998</xref>), <italic>ESR1</italic> (<xref ref-type="bibr" rid="B29">Clapauch et al., 2014</xref>), <italic>IL10</italic> (<xref ref-type="bibr" rid="B21">Cattaruzza et al., 2003</xref>), <italic>GCH1</italic> (<xref ref-type="bibr" rid="B103">Katusic et al., 1998</xref>; <xref ref-type="bibr" rid="B252">Zhang et al., 2007</xref>), <italic>IL1B</italic> (<xref ref-type="bibr" rid="B103">Katusic et al., 1998</xref>), <italic>IL4</italic> (<xref ref-type="bibr" rid="B31">Coccia et al., 2000</xref>), <italic>P2RX7</italic> (<xref ref-type="bibr" rid="B69">Gendron et al., 2003</xref>), <italic>SOD2</italic> (<xref ref-type="bibr" rid="B62">Fridovich, 1978</xref>). Furthermore, catecholamines including noradrenaline, adrenaline and dopamine have multiple functions in the brain and spinal cord including pain perception and processing (<xref ref-type="bibr" rid="B45">D’Mello and Dickenson, 2008</xref>). Catechol-<italic>O</italic>-methyltransferase, encoded by the <italic>COMT</italic> gene, is one of several enzymes that degrade dopamine, noradrenaline and adrenaline and has become one of the most frequently addressed genes in pain research (<xref ref-type="bibr" rid="B163">Nackley et al., 2006</xref>).</p>
<p>Finally, subset #3 (<italic>d</italic> = 30) consists of genes repeatedly shown to play a role in the genetic modulation of persisting pain in humans or, by contrast, included a few novel items only recently published in the context of pain. This included members of the transient receptor potential (TRP) family (<italic>TRPA1, TRPM8, TRPV4</italic>) that are expressed at nociceptors and which are well established players in the perception of pain via their excitation by chemical, thermal or mechanical stimuli (<xref ref-type="bibr" rid="B30">Clapham, 2003</xref>). This similarly applies to the opioidergic system represented by the inclusion of the genes coding for the major opioid receptors (<italic>OPRM1, OPRK1 OPRD1</italic>), which have been associated with variations in pain or opioid response in various settings (<xref ref-type="bibr" rid="B141">Lötsch and Geisslinger, 2005</xref>). The most important of this group, the μ-opioid receptor encoded by the <italic>OPRM1</italic> gene, carriers several variants of which the 118 A&gt;G (rs1799971) has been studied most extensively since the early description of its association with a functional phenotype in humans (<xref ref-type="bibr" rid="B145">Lötsch et al., 2002</xref>).</p>
<p>Almost half of the present sets of genes were chosen based on a computational functional genomics analysis that attributed persisting pain to GO processes of “learning or memory” and “nervous system development” (<xref ref-type="bibr" rid="B231">Ultsch et al., 2016</xref>) as likely to reflect systemic features of persisting pain. This implied a functional bias and therefore, the present set of <italic>d</italic> = 77 genes (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>) was analyzed whether this bias prevailed when comparing it with the alternative sets of human genes proposed to modulate persisting pain (<xref ref-type="bibr" rid="B161">Mogil, 2012</xref>; <xref ref-type="bibr" rid="B254">Zorina-Lichtenwalter et al., 2016</xref>). As applied previously (<xref ref-type="bibr" rid="B131">Lippmann et al., 2018</xref>), the biological roles of the set of <italic>d</italic> = 77 genes were queried from the Gene Ontology knowledgebase (GO)<sup><xref ref-type="fn" rid="fn011">11</xref></sup> (<xref ref-type="bibr" rid="B6">Ashburner et al., 2000</xref>) where the knowledge about the biological processes, the molecular functions and the cellular components of genes is formulated using a controlled and clearly defined vocabulary of GO terms. Particular biological roles of the set of <italic>d</italic> = 77 genes, among all human genes, were analyzed by means of over-representation analysis (ORA). This compared the occurrence of the particular GO terms associated with the present set of genes with their expected occurrence by chance (<xref ref-type="bibr" rid="B7">Backes et al., 2007</xref>). In contrast to enrichment analysis, any quantitative criteria such as gene expression values are disregarded (<xref ref-type="bibr" rid="B7">Backes et al., 2007</xref>). The analyses were performed using our R library “dbtORA” (<xref ref-type="bibr" rid="B131">Lippmann et al., 2018</xref>)<sup><xref ref-type="fn" rid="fn012">12</xref></sup> on the R software environment (version 3.4.2 for Linux; <xref ref-type="bibr" rid="B184">R Development Core Team, 2008</xref>)<sup><xref ref-type="fn" rid="fn013">13</xref></sup>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Top–down representation of the annotations (GO terms) representing the taxonomy of the functional differences between the set of <italic>d</italic> = 77 genes included in the proposed NGS panel of persisting pain and two alternative proposals of genes modulating persisting pain in humans (<xref ref-type="bibr" rid="B161">Mogil, 2012</xref>; <xref ref-type="bibr" rid="B254">Zorina-Lichtenwalter et al., 2016</xref>). The figure represents the results of an over-representation analysis of the present set of <italic>d</italic> = 77 genes against the reference comprising the set intersection of the alternative gene lists. A <italic>p</italic>-value threshold of 0.01 and Bonferroni α-correction were applied. Significant terms are shown as colored circles with the number of member genes, the number of expected genes by change and the significance of the deviation of the observed from the expected number of genes indicated (yellow = headline, red = significant term, blue = significant term located as a leave at the end of a taxonomy in the polyhierarchy). The graphical representation follows the standard of the GO knowledgebase, where GO terms are related to each other by “is-a,” “part-of,” and “regulates” relationships forming a polyhierarchy organized in a directed acyclic graph (DAG, <xref ref-type="bibr" rid="B226">Thulasiraman and Swamy, 1992</xref>). The figure has been created using our R library “dbtORA” (<ext-link ext-link-type="uri" xlink:href="https://github.com/IME-TMP-FFM/dbtORA">https://github.com/IME-TMP-FFM/dbtORA</ext-link>, <xref ref-type="bibr" rid="B131">Lippmann et al., 2018</xref>) on the R software package (version 3.4.2 for Linux; <ext-link ext-link-type="uri" xlink:href="http://CRAN.R-project.org/">http://CRAN.R-project.org/</ext-link>, <xref ref-type="bibr" rid="B184">R Development Core Team, 2008</xref>) and the freely available graph visualization software GraphViz (<ext-link ext-link-type="uri" xlink:href="http://www.graphviz.org">http://www.graphviz.org</ext-link>, <xref ref-type="bibr" rid="B65">Gansner and North, 2000</xref>).</p>
</caption>
<graphic xlink:href="fphar-09-01008-g004"></graphic>
</fig>
<p>Surprisingly, the results of this analysis indicated that the functional bias of the present gene set toward “learning or memory” (GO:0007611) and “nervous system development” (GO:0007399) was not maintained against the alternative gene sets. Instead, a few more general GO terms such as “behavior” (“single organism behavior,” GO:0044708), or “response to organic cyclic compound” (GO:0014070) and response to alkaloid (GO:0043279), which could be identified as morphine and cocaine when repeating the analysis with a less conservative α-correction (further details not shown), were overrepresented, as well as the pain specific term “sensory perception of pain” (GO:0019233). A possible explanation that the selection bias of the present gene set was not maintained when comparing it with alternative proposals is that the two biological processes, “learning or memory” and “nervous system development,” reflect indeed an important biological function of persisting pain and even when choosing candidate genes without having these processes in mind as for the alternative gene sets, they are nevertheless included. This may be regarded as support for the present gene set as suitable candidates for future association studies with persisting pain phenotypes.</p>
<p>Although the present gene set has been assembled with a focus of a relevance to pain, many of its members have pharmacological implications. Specifically, 58 of the 77 genes (75%) have been chosen as targets of analgesics, approved or under current clinical development (<bold>Table <xref ref-type="table" rid="T3">3</xref></bold>). Moreover, several of the genes in the present NGS panel have been implicated in pharmacogenetic modulations of drug effects (<bold>Table <xref ref-type="table" rid="T4">4</xref></bold>). Possibly the most widely studied gene in analgesic research is <italic>OPRM1</italic> because coding for the primary target of opioids (<xref ref-type="bibr" rid="B178">Peiro et al., 2016</xref>). Several polymorphisms have been described in <italic>OPRM1</italic>, among which the best characterized may be rs1799971 (<italic>OPRM1</italic> 118A&gt;G) that leads to an asparagine to aspartate substitution at the extracellular terminal of the receptor protein (<xref ref-type="bibr" rid="B9">Bond et al., 1998</xref>). May studies have addressed this variant (for reviews, see <xref ref-type="bibr" rid="B239">Walter et al., 2013</xref>; <xref ref-type="bibr" rid="B217">Somogyi et al., 2015</xref>). Summarizing its effects, the variant is associated with decreased receptor expression and signaling efficiency (<xref ref-type="bibr" rid="B170">Oertel et al., 2012</xref>) which leads to reproducibly reduced pharmacodynamic effects in human experimental settings while the effect size seems insufficient to be a major factor of opioid response in clinical settings, despite several reports of modulations of opioid demands or side effects. For example, subjects carrying the 118A&gt;G variant were found to have a reduced response to morphine treatment (<xref ref-type="bibr" rid="B95">Hwang et al., 2014</xref>), reduced analgesic response to alfentanil (<xref ref-type="bibr" rid="B171">Oertel et al., 2006</xref>) and demanded higher doses of morphine for pain relief (<xref ref-type="bibr" rid="B112">Klepstad et al., 2004</xref>; <xref ref-type="bibr" rid="B95">Hwang et al., 2014</xref>). However, the importance of this variant seems to be comparatively high in patients with an Asian ethnic background, which might be related to the higher allelic frequency as compared to other ethnicities. <italic>COMT</italic> is a key modulator of dopaminergic neurotransmission and in the signaling response to opioids The Val158Met polymorphism (rs4680) causes an amino acid substitution in the enzyme, which reduced the enzyme active to a forth (<xref ref-type="bibr" rid="B178">Peiro et al., 2016</xref>). Carriers of the homozygous Met/Met variant had lower morphine requirements than those with a the wild type <italic>COMT</italic> (<xref ref-type="bibr" rid="B185">Rakvag et al., 2005</xref>). Furthermore, a modulation of the effects of <italic>TRPV1</italic> targeting analgesics is supported by observations that intronic <italic>TRPV1</italic> variants were associated with insensitivity to capsaicin (<xref ref-type="bibr" rid="B177">Park et al., 2007</xref>) while the coding <italic>TRPV1</italic> variant rs8065080 was associated with altered responses to experimentally induced pain(<xref ref-type="bibr" rid="B108">Kim et al., 2004</xref>). Moreover, gain-of-function mutations in <italic>TRPV1</italic> have been associated with increased pain sensitivity (<xref ref-type="bibr" rid="B10">Boukalova et al., 2014</xref>), for which <italic>TRPV1</italic> antagonists would enable a specific pharmacogenetics-based personalized cure.</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Current targeting of the genes included in the proposed NGS panel of persisting pain by novel drugs that are currently under active clinical development and include analgesia as the main clinical target or at least as one of the intended clinical indication.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Status</th>
<th align="left" colspan="1" rowspan="1" valign="top">Drug</th>
<th align="left" colspan="1" rowspan="1" valign="top">Action</th>
<th align="left" colspan="1" rowspan="1" valign="top">Company</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABHD12</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABHD16A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABHD6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Benzylpiperidin methanone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acylamino-Acid-Releasing Enzyme</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scripps Research Institute</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADCY1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Under Active Development</td>
<td align="left" colspan="1" rowspan="1" valign="top">NB-001</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adenylate Cyclase Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Forever Cheer International</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADRB2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II/III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gencaro</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">ARCA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BDNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase I</td>
<td align="left" colspan="1" rowspan="1" valign="top">CXB-909</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nerve Growth Factor (NGF) Enhancers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Krenitsky</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CACNG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hanfangchin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Calcium Channel Blockers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Millenia Hope Kaken</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CDK5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Biological Testing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Litvinolin</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDK5/p25 Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hong Kong University</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CHRNB2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Biological Testing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epiboxidine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nicotinic alpha4beta2 Receptor Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfizer</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Registered</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epidiolex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cannabinoid Receptor Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">InSys Therapeutics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>COMT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Clinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nitecapone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Catechol-<italic>O</italic>-Methyl Transferase (COMT) Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Orion</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CSF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DLG4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">AB-125</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lundbeck University of Copenhagen</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II/III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ecopipam</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine D1 Receptor (DRD1) Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Merck &amp; Co.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II/III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sarizotan hydrochloride</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine D2 Receptor (DRD2) Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Newron</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brilaroxazine</td>
<td align="left" colspan="1" rowspan="1" valign="top">D3 Receptor (DRD3) Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reviva Pharmaceuticals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Biological Testing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mesulergine hydrochloride</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine Receptor Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Novartis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>EGR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brivoligide</td>
<td align="left" colspan="1" rowspan="1" valign="top">EGR1 Expression Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adynxx</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zindoxifene</td>
<td align="left" colspan="1" rowspan="1" valign="top">Selective Estrogen Receptor Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Evonik</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FAAH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase I/II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Minerval</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fatty Acid Amide Hydrolase (FAAH) Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scripps Research Institute</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FKBP5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Barusiban</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oxytocin Receptor Antagonist</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ferring</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FOS</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Registered</td>
<td align="left" colspan="1" rowspan="1" valign="top">Macrilen</td>
<td align="left" colspan="1" rowspan="1" valign="top">FOS Expression Enhancers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Strongbridge Biopharma</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FYN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bafetinib</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fyn Kinase Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nippon Shinyaku</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GABRA5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ganaxolone</td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA(A) Receptor Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Marinus Pharmaceuticals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GALR2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">NAX-810-2</td>
<td align="left" colspan="1" rowspan="1" valign="top">GAL2 Receptor Ligands</td>
<td align="left" colspan="1" rowspan="1" valign="top">NeuroAdjuvants</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GCH1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GDNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Edonerpic maleate</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Toyama</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GFRA1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GPR132</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dimiracetam</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Metys Pharmaceuticals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase I</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dexanabinol</td>
<td align="left" colspan="1" rowspan="1" valign="top">NMDA Receptor Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">e-Therapeutics Pharmos</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRIN2B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase I</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gacyclidine</td>
<td align="left" colspan="1" rowspan="1" valign="top">NMDA Receptor Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">INSERM</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRM5</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mavoglurant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Novartis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HCN2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Clinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ivabradine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adrenoceptor Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Servier</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HLA-DQB1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HLA-DRB1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HRH3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase I</td>
<td align="left" colspan="1" rowspan="1" valign="top">Immethridine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histalean</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abbott</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR1A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Eltoprazine hydrochloride</td>
<td align="left" colspan="1" rowspan="1" valign="top">5-HT1A Receptor Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Elto Pharma</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Midomafetamine</td>
<td align="left" colspan="1" rowspan="1" valign="top">5-HT2 Receptor Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Assoc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL10</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">BT-063</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators Anti-IL-10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Biotest AG</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL1B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resunab</td>
<td align="left" colspan="1" rowspan="1" valign="top">IL-1beta Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Corbus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL1R2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Azintrel</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators Anti-IL-6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jazz Pharmaceuticals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KCNS1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Crotamine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Voltage-Gated K(V) Channel Blockers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Celtic Biotech</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KIT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vatalanib succinate</td>
<td align="left" colspan="1" rowspan="1" valign="top">KIT (C-KIT) Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Novartis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LTB4R</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coversin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Akari Therapeutics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>LTB4R2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coversin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Akari Therapeutics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NGF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tanezumab</td>
<td align="left" colspan="1" rowspan="1" valign="top">Anti-Nerve Growth Factor (NGF)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfizer</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NTF4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NTRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Danusertib</td>
<td align="left" colspan="1" rowspan="1" valign="top">NTRK1 Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfizer</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRD1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Metenkephalin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Delta-Opioid Receptor Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">TNI Pharmaceuticals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Morphine glucuronide</td>
<td align="left" colspan="1" rowspan="1" valign="top">Opioid Receptor Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">PAION</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Registered</td>
<td align="left" colspan="1" rowspan="1" valign="top">Naltrexone</td>
<td align="left" colspan="1" rowspan="1" valign="top">mu-Opioid Receptor Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfizer</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OXT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Barusiban</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oxytocin Receptor Antagonist</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ferring</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>P2RX7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">BIL-06v</td>
<td align="left" colspan="1" rowspan="1" valign="top">Anti-P2RX7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Biosceptre International</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PLCB1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Biological Testing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vinaxanthone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Roche</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PRKCG</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rydapt</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein Kinase C (PKC) Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yeda</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PRNP</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTPRZ1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RELN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preclinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">IAIPs</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serine Protease Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">ProThera Biologics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RET</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Danusertib</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ret (RET) Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfizer</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RUNX1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>S100B</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCN9A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Priralfinamide</td>
<td align="left" colspan="1" rowspan="1" valign="top">Voltage-Gated Sodium Channel Blockers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Newron</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SLC6A4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Litoxetine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signal Transduction Modulators</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sanofi</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Avasopasem manganese</td>
<td align="left" colspan="1" rowspan="1" valign="top">Superoxide Dismutase (SOD) Mimetics</td>
<td align="left" colspan="1" rowspan="1" valign="top">MetaPhore</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TLR4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Eritoran tetrasodium</td>
<td align="left" colspan="1" rowspan="1" valign="top">Toll-Like Receptor 4 (TLR4) Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Eisai</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase III</td>
<td align="left" colspan="1" rowspan="1" valign="top">Givinostat hydrochloride</td>
<td align="left" colspan="1" rowspan="1" valign="top">TNF-alpha Release Inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Italfarmaco</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPA1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cannabidivarin</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRPA1 Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">GW Pharmaceuticals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPM8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cannabidivarin</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRPM8 Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">GW Pharmaceuticals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase I/II</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resiniferatoxin</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRPV1 (Vanilloid VR1 Receptor) Agonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">Icos</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phase II</td>
<td align="left" colspan="1" rowspan="1" valign="top">GSK-2798745</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRPV4 Antagonists</td>
<td align="left" colspan="1" rowspan="1" valign="top">GlaxoSmithKline</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TSPO</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Clinical</td>
<td align="left" colspan="1" rowspan="1" valign="top">[11C]CB-184</td>
<td align="left" colspan="1" rowspan="1" valign="top">Translocator Protein (TSPO) Ligands</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tokyo Metrop Geriatr Hosp Inst Gerontol</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>The information was queried from the Thomson Reuters Integrity database at <ext-link ext-link-type="uri" xlink:href="https://integrity.thomson-pharma.com">https://integrity.thomson-pharma.com</ext-link> on July 11, 2018.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p>Summary of variants in genes included in the proposed NGS panel of persisting pain, that have been implicated in a pharmacogenetic context to modulate the effects of drugs administered for the treatment of pain or as disease modifying therapeutics in painful disease.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Modulated process</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Variant</th>
<th align="left" colspan="1" rowspan="1" valign="top">Affected drug</th>
<th align="left" colspan="1" rowspan="1" valign="top">Findings</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G protein coupled signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>COMT</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4680 (Val158Met)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Morphine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carriers of val/val and val/met genotype required higher morphine dose compared to carriers of met/met genotype</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B187">Reyes-Gibby et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6275</td>
<td align="left" colspan="1" rowspan="1" valign="top">Heroine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism is associated with decreased likelihood of headache disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B20">Cargnin et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DRD4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1800955</td>
<td align="left" colspan="1" rowspan="1" valign="top">Heroine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism had lower pain threshold versus CC/CT controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B86">Ho et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRM1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1799971 (A118G)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Various opioids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tendency toward increased pain in dose-dependent manner with the μ-opioid receptor variant 118G</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B140">Lötsch et al., 2009c</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OPRK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1051660</td>
<td align="left" colspan="1" rowspan="1" valign="top">Morphine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patients with the polymorphism and cancer-related pain may require a reduced dose escalation of morphine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B23">Chatti et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotransmitters</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BDNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs6265</td>
<td align="left" colspan="1" rowspan="1" valign="top">Various opioids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism is associated with decreased likelihood of headache disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B20">Cargnin et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HTR2A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs12584920</td>
<td align="left" colspan="1" rowspan="1" valign="top">Various opioids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased likelihood of having chronic widespread pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B166">Nicholl et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ion Channels</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TRPV1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7 intronic SNPs</td>
<td align="left" colspan="1" rowspan="1" valign="top">Capsaicin</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRPV1 polymorphisms had only 50% of the mRNA and protein expression levels of normally sensing subjects</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B177">Park et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Proinflammatory Cytokines</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs1800795</td>
<td align="left" colspan="1" rowspan="1" valign="top">Etanercept</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism is associated with increased response to adalimumab, etanercept or infliximab in people with painful Arthritis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B37">Davila-Fajardo et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Other</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ESR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2234693</td>
<td align="left" colspan="1" rowspan="1" valign="top">Leflunomide</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism is associated with increased response to leflunomide in women with painful Arthritis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B52">Dziedziejko et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FAAH</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2295632</td>
<td align="left" colspan="1" rowspan="1" valign="top">Various opioids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism is associated with increased risk of Respiratory Insufficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B8">Biesiada et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TLR4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4986790</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methotrexate</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism associated with increased risk of adverse drug events when treated with folic acid and methotrexate in people with Arthritis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B114">Kooloos et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TNF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs361525</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infliximab</td>
<td align="left" colspan="1" rowspan="1" valign="top">Polymorphism is associated with increased response to infliximab in people with painful Arthritis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B152">Maxwell et al., 2008</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>The information was derived by literature search and by querying the Pharmacogenetics Research Network/Knowledge base at <ext-link ext-link-type="uri" xlink:href="http://www.pharmgkb.org">http://www.pharmgkb.org</ext-link> (accessed in July 2018). Only key or example references are given.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Conclusion</title>
<p>The breakthrough in mapping the whole human genome (<xref ref-type="bibr" rid="B122">Lander et al., 2001</xref>; <xref ref-type="bibr" rid="B237">Venter et al., 2001</xref>) along with genome wide association studies (GWAS) has led to rapid advances in the knowledge of the genetic bases of human diseases (<xref ref-type="bibr" rid="B243">Wellcome Trust Case Control and Consortium, 2007</xref>). Genetic research in pain medicine has directed to the recognition of genes in which variants influence pain behavior, post-operative drug requirements, and the temporal developments of pain toward persistence (<xref ref-type="bibr" rid="B98">James, 2013</xref>). While many candidate gene association studies have identified multiple genes relevant for pain phenotypes (<xref ref-type="bibr" rid="B59">Fillingim et al., 2008</xref>), pain related genetic studies have so far been owned by investigations of a limited number of genes. Roughly ten genes or gene complexes account for over half of the extant findings and several of these candidate gene associations have held up in replication (<xref ref-type="bibr" rid="B161">Mogil, 2012</xref>). The selection of variants has been limited and they have been addressed in most studies repeatedly, leading to the perception that genetic research in pain produces often unsatisfactory results (<xref ref-type="bibr" rid="B160">Mogil, 2009</xref>). However, this may soon change with the arise of new technologies. In this manuscript, we present a validated NGS assay for a set of 77 genes supported by empirical evidence and computational functional genomics analyses as relevant factors modulating the risk for persisting pain or its clinical picture.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>JL, DK, and EK conceived and designed the experiments. DK performed the experiments. JL and DK analyzed the data and wrote the paper. CL provided methodological expertise and bioinformatical tools. DK and JL interpreted the results. EK and MK provided DNA samples.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work has been funded by the European Union Seventh Framework Programme (FP7/2007 – 2013) under grant agreement no. 602919 (“GLORIA”, EK and JL) and the LandesOffensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz (LOEWE), LOEWE-Zentrum für Translationale Medizin und Pharmakologie (JL). These public funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</fn>
</fn-group>
<fn-group>
<fn id="fn01">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://amigo.geneontology.org/amigo/term/GO:0007611">http://amigo.geneontology.org/amigo/term/GO:0007611</ext-link>
</p>
</fn>
<fn id="fn02">
<label>2</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://amigo.geneontology.org/amigo/term/GO:0007399">http://amigo.geneontology.org/amigo/term/GO:0007399</ext-link>
</p>
</fn>
<fn id="fn03">
<label>3</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.jbldesign.com/jmogil/enter.html">http://www.jbldesign.com/jmogil/enter.html</ext-link>
</p>
</fn>
<fn id="fn04">
<label>4</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://gloria.helsinki.fi">http://gloria.helsinki.fi</ext-link>
</p>
</fn>
<fn id="fn05">
<label>5</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.ampliseq.com">http://www.ampliseq.com</ext-link>
</p>
</fn>
<fn id="fn06">
<label>6</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.jbldesign.com/jmogil/enter.html">http://www.jbldesign.com/jmogil/enter.html</ext-link>
</p>
</fn>
<fn id="fn07">
<label>7</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim">http://www.ncbi.nlm.nih.gov/omim</ext-link>
</p>
</fn>
<fn id="fn08">
<label>8</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gene">http://www.ncbi.nlm.nih.gov/gene</ext-link>
</p>
</fn>
<fn id="fn09">
<label>9</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org">http://www.genecards.org</ext-link>
</p>
</fn>
<fn id="fn010">
<label>10</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes">https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes</ext-link>
</p>
</fn>
<fn id="fn011">
<label>11</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org/">http://www.geneontology.org/</ext-link>
</p>
</fn>
<fn id="fn012">
<label>12</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://github.com/IME-TMP-FFM/dbtORA">https://github.com/IME-TMP-FFM/dbtORA</ext-link>
</p>
</fn>
<fn id="fn013">
<label>13</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://CRAN.R-project.org/">http://CRAN.R-project.org/</ext-link>
</p>
</fn>
</fn-group>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2018.01008/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2018.01008/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Table_1.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM2">
<media xlink:href="Table_2.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM3">
<media xlink:href="Table_3.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbadie</surname><given-names>C.</given-names></name><name><surname>Besson</surname><given-names>J. M.</given-names></name><name><surname>Calvino</surname><given-names>B.</given-names></name></person-group> (<year>1994</year>). <article-title>c-Fos expression in the spinal cord and pain-related symptoms induced by chronic arthritis in the rat are prevented by pretreatment with <italic>Freund adjuvant</italic>.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>14</volume>
<fpage>5865</fpage>–<lpage>5871</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.14-10-05865.1994</pub-id>
<pub-id pub-id-type="pmid">7931549</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achkar</surname><given-names>J.-P.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>De Bakker</surname><given-names>P. I. W.</given-names></name><name><surname>Bellone</surname><given-names>G.</given-names></name><name><surname>Rebert</surname><given-names>N.</given-names></name><name><surname>Scott</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis.</article-title>
<source/><italic>Genes Immun.</italic>
<volume>13</volume>
<fpage>245</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1038/gene.2011.79</pub-id>
<pub-id pub-id-type="pmid">22170232</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Eitan</surname><given-names>L. N.</given-names></name><name><surname>Jaradat</surname><given-names>S. A.</given-names></name><name><surname>Su</surname><given-names>S. Y.</given-names></name><name><surname>Tay</surname><given-names>G. K.</given-names></name><name><surname>Hulse</surname><given-names>G. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent.</article-title>
<source/><italic>Pharmgen. Pers. Med.</italic>
<volume>5</volume>
<fpage>99</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.2147/PGPM.S33351</pub-id>
<pub-id pub-id-type="pmid">23226066</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarado</surname><given-names>S.</given-names></name><name><surname>Tajerian</surname><given-names>M.</given-names></name><name><surname>Millecamps</surname><given-names>M.</given-names></name><name><surname>Suderman</surname><given-names>M.</given-names></name><name><surname>Stone</surname><given-names>L. S.</given-names></name><name><surname>Szyf</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Peripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>9</volume>:<issue>21</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-9-21</pub-id>
<pub-id pub-id-type="pmid">23597049</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreoli</surname><given-names>V.</given-names></name><name><surname>De Marco</surname><given-names>E. V.</given-names></name><name><surname>Trecroci</surname><given-names>F.</given-names></name><name><surname>Cittadella</surname><given-names>R.</given-names></name><name><surname>Di Palma</surname><given-names>G.</given-names></name><name><surname>Gambardella</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease.</article-title>
<source/><italic>J. Neural Transm. (Vienna)</italic>
<volume>121</volume>
<fpage>533</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="pmid">24292895</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M.</given-names></name><name><surname>Ball</surname><given-names>C. A.</given-names></name><name><surname>Blake</surname><given-names>J. A.</given-names></name><name><surname>Botstein</surname><given-names>D.</given-names></name><name><surname>Butler</surname><given-names>H.</given-names></name><name><surname>Cherry</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Gene ontology: tool for the unification of biology.</article-title>
<source/><italic>Gene Ontol. Consortium. Nat. Genet.</italic>
<volume>25</volume>
<fpage>25</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/75556</pub-id>
<pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Backes</surname><given-names>C.</given-names></name><name><surname>Keller</surname><given-names>A.</given-names></name><name><surname>Kuentzer</surname><given-names>J.</given-names></name><name><surname>Kneissl</surname><given-names>B.</given-names></name><name><surname>Comtesse</surname><given-names>N.</given-names></name><name><surname>Elnakady</surname><given-names>Y. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>GeneTrail–advanced gene set enrichment analysis.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>35</volume>
<fpage>W186</fpage>–<lpage>W192</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm323</pub-id>
<pub-id pub-id-type="pmid">17526521</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biesiada</surname><given-names>J.</given-names></name><name><surname>Chidambaran</surname><given-names>V.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Martin</surname><given-names>L. J.</given-names></name><name><surname>Meller</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy.</article-title>
<source/><italic>Pharmacogenomics</italic>
<volume>15</volume>
<fpage>1749</fpage>–<lpage>1762</lpage>. <pub-id pub-id-type="doi">10.2217/pgs.14.137</pub-id>
<pub-id pub-id-type="pmid">25493568</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>C.</given-names></name><name><surname>Laforge</surname><given-names>K. S.</given-names></name><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Melia</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Borg</surname><given-names>L.</given-names></name></person-group> (<year>1998</year>). <article-title>Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>9608</fpage>–<lpage>9613</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.16.9608</pub-id>
<pub-id pub-id-type="pmid">9689128</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukalova</surname><given-names>S.</given-names></name><name><surname>Touska</surname><given-names>F.</given-names></name><name><surname>Marsakova</surname><given-names>L.</given-names></name><name><surname>Hynkova</surname><given-names>A.</given-names></name><name><surname>Sura</surname><given-names>L.</given-names></name><name><surname>Chvojka</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Gain-of-function mutations in the transient receptor potential channels TRPV1 and TRPA1: how painful?</article-title>
<source/><italic>Physiol. Res.</italic>
<volume>63(Suppl. 1)</volume>
<fpage>S205</fpage>–<lpage>S213</lpage>.<pub-id pub-id-type="pmid">24564660</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourinet</surname><given-names>E.</given-names></name><name><surname>Altier</surname><given-names>C.</given-names></name><name><surname>Hildebrand</surname><given-names>M. E.</given-names></name><name><surname>Trang</surname><given-names>T.</given-names></name><name><surname>Salter</surname><given-names>M. W.</given-names></name><name><surname>Zamponi</surname><given-names>G. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Calcium-permeable ion channels in pain signaling.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>94</volume>
<fpage>81</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00023.2013</pub-id>
<pub-id pub-id-type="pmid">24382884</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>L.</given-names></name><name><surname>Torres-Sanchez</surname><given-names>S.</given-names></name><name><surname>Alba-Delgado</surname><given-names>C.</given-names></name><name><surname>Mico</surname><given-names>J. A.</given-names></name><name><surname>Berrocoso</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats.</article-title>
<source/><italic>Eur. Neuropsychopharmacol.</italic>
<volume>24</volume>
<fpage>996</fpage>–<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2014.01.011</pub-id>
<pub-id pub-id-type="pmid">24491949</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo-Hernández</surname><given-names>M.</given-names></name><name><surname>Corleto</surname><given-names>J. A.</given-names></name><name><surname>Barragán-Iglesias</surname><given-names>P.</given-names></name><name><surname>González-Ramírez</surname><given-names>R.</given-names></name><name><surname>Pineda-Farias</surname><given-names>J. B.</given-names></name><name><surname>Felix</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The α5 subunit containing GABAA receptors contribute to chronic pain.</article-title>
<source/><italic>Pain</italic>
<volume>157</volume>
<fpage>613</fpage>–<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000410</pub-id>
<pub-id pub-id-type="pmid">26545088</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruera</surname><given-names>G.</given-names></name><name><surname>Pepe</surname><given-names>F.</given-names></name><name><surname>Malapelle</surname><given-names>U.</given-names></name><name><surname>Pisapia</surname><given-names>P.</given-names></name><name><surname>Mas</surname><given-names>A. D.</given-names></name><name><surname>Di Giacomo</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.</article-title>
<source/><italic>Oncotarget</italic>
<volume>9</volume>
<fpage>26279</fpage>–<lpage>26290</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.25180</pub-id>
<pub-id pub-id-type="pmid">29899858</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchheit</surname><given-names>T.</given-names></name><name><surname>Van De Ven</surname><given-names>T.</given-names></name><name><surname>Shaw</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Epigenetics and the transition from acute to chronic pain.</article-title>
<source/><italic>Pain. Med.</italic>
<volume>13</volume>
<fpage>1474</fpage>–<lpage>1490</lpage>. <pub-id pub-id-type="doi">10.1111/j.1526-4637.2012.01488.x</pub-id>
<pub-id pub-id-type="pmid">22978429</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buskila</surname><given-names>D.</given-names></name><name><surname>Cohen</surname><given-names>H.</given-names></name><name><surname>Neumann</surname><given-names>L.</given-names></name><name><surname>Ebstein</surname><given-names>R. P.</given-names></name></person-group> (<year>2004</year>). <article-title>An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>9</volume>
<fpage>730</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001568</pub-id>
<pub-id pub-id-type="pmid">15052273</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cajanus</surname><given-names>K.</given-names></name><name><surname>Holmström</surname><given-names>E. J.</given-names></name><name><surname>Wessman</surname><given-names>M.</given-names></name><name><surname>Anttila</surname><given-names>V.</given-names></name><name><surname>Kaunisto</surname><given-names>M. A.</given-names></name><name><surname>Kalso</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer.</article-title>
<source/><italic>Pain</italic>
<volume>157</volume>
<fpage>361</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000398</pub-id>
<pub-id pub-id-type="pmid">26808012</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camilleri</surname><given-names>M.</given-names></name><name><surname>Klee</surname><given-names>E. W.</given-names></name><name><surname>Shin</surname><given-names>A.</given-names></name><name><surname>Carlson</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Grover</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.</article-title>
<source/><italic>Am. J. Physiol. Gastrointest. Liver Physiol.</italic>
<volume>306</volume>
<fpage>G13</fpage>–<lpage>G26</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00294.2013</pub-id>
<pub-id pub-id-type="pmid">24200957</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camon</surname><given-names>E.</given-names></name><name><surname>Magrane</surname><given-names>M.</given-names></name><name><surname>Barrell</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>V.</given-names></name><name><surname>Dimmer</surname><given-names>E.</given-names></name><name><surname>Maslen</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The gene ontology annotation (GOA) database: sharing knowledge in uniprot with Gene Ontology.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>32</volume>
<fpage>D262</fpage>–<lpage>D266</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh021</pub-id>
<pub-id pub-id-type="pmid">14681408</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cargnin</surname><given-names>S.</given-names></name><name><surname>Viana</surname><given-names>M.</given-names></name><name><surname>Sances</surname><given-names>G.</given-names></name><name><surname>Bianchi</surname><given-names>M.</given-names></name><name><surname>Ghiotto</surname><given-names>N.</given-names></name><name><surname>Tassorelli</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache.</article-title>
<source/><italic>Eur. J. Clin. Pharmacol.</italic>
<volume>70</volume>
<fpage>1195</fpage>–<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1007/s00228-014-1726-6</pub-id>
<pub-id pub-id-type="pmid">25096645</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaruzza</surname><given-names>M.</given-names></name><name><surname>Slodowski</surname><given-names>W.</given-names></name><name><surname>Stojakovic</surname><given-names>M.</given-names></name><name><surname>Krzesz</surname><given-names>R.</given-names></name><name><surname>Hecker</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>
<fpage>37874</fpage>–<lpage>37880</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M301670200</pub-id>
<pub-id pub-id-type="pmid">12857749</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceolin</surname><given-names>L.</given-names></name><name><surname>Siqueira</surname><given-names>D. R.</given-names></name><name><surname>Romitti</surname><given-names>M.</given-names></name><name><surname>Ferreira</surname><given-names>C. V.</given-names></name><name><surname>Maia</surname><given-names>A. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular basis of medullary thyroid carcinoma: the role of RET polymorphisms.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>13</volume>
<fpage>221</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.3390/ijms13010221</pub-id>
<pub-id pub-id-type="pmid">22312249</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatti</surname><given-names>I.</given-names></name><name><surname>Woillard</surname><given-names>J. B.</given-names></name><name><surname>Mili</surname><given-names>A.</given-names></name><name><surname>Creveaux</surname><given-names>I.</given-names></name><name><surname>Ben Charfeddine</surname><given-names>I.</given-names></name><name><surname>Feki</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genetic analysis of mu and kappa opioid receptor and COMT enzyme in cancer pain tunisian patients under opioid treatment.</article-title>
<source/><italic>Iran J. Public Health</italic>
<volume>46</volume>
<fpage>1704</fpage>–<lpage>1711</lpage>. <pub-id pub-id-type="pmid">29259946</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C. L.</given-names></name><name><surname>Broom</surname><given-names>D. C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>De Nooij</surname><given-names>J. C.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Cen</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain.</article-title>
<source/><italic>Neuron</italic>
<volume>49</volume>
<fpage>365</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.10.036</pub-id>
<pub-id pub-id-type="pmid">16446141</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>T.-L.</given-names></name><name><surname>Wang</surname><given-names>L.-M.</given-names></name></person-group> (<year>2014</year>). <article-title>The association of CSF-1 gene polymorphism with chronic periodontitis in the Han Chinese population.</article-title>
<source/><italic>J. Periodontol.</italic>
<volume>85</volume>
<fpage>e304</fpage>–<lpage>e312</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2014.130688</pub-id>
<pub-id pub-id-type="pmid">24592910</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Brosnan</surname><given-names>C. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Regulation of immune response by P2X7 receptor.</article-title>
<source/><italic>Crit. Rev. Immunol.</italic>
<volume>26</volume>
<fpage>499</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevImmunol.v26.i6.30</pub-id><pub-id pub-id-type="pmid">17341191</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Williamson</surname><given-names>V. S.</given-names></name><name><surname>An</surname><given-names>S.-S.</given-names></name><name><surname>Hettema</surname><given-names>J. M.</given-names></name><name><surname>Aggen</surname><given-names>S. H.</given-names></name><name><surname>Neale</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Cannabinoid receptor 1 gene association with nicotine dependence.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>65</volume>
<fpage>816</fpage>–<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.65.7.816</pub-id>
<pub-id pub-id-type="pmid">18606954</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>P.</given-names></name><name><surname>Reiser</surname><given-names>H.</given-names></name></person-group> (<year>1998</year>). <article-title>IL-4: role in disease and regulation of production.</article-title>
<source/><italic>Clin. Exp. Immunol.</italic>
<volume>113</volume>
<fpage>317</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2249.1998.00690.x</pub-id><pub-id pub-id-type="pmid">9737656</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapauch</surname><given-names>R.</given-names></name><name><surname>Mourao</surname><given-names>A. F.</given-names></name><name><surname>Mecenas</surname><given-names>A. S.</given-names></name><name><surname>Maranhao</surname><given-names>P. A.</given-names></name><name><surname>Rossini</surname><given-names>A.</given-names></name><name><surname>Bouskela</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Endothelial function and insulin resistance in early postmenopausal women with cardiovascular risk factors: importance of ESR1 and NOS3 polymorphisms.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e103444</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103444</pub-id>
<pub-id pub-id-type="pmid">25077953</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapham</surname><given-names>D. E.</given-names></name></person-group> (<year>2003</year>). <article-title>TRP channels as cellular sensors.</article-title>
<source/><italic>Nature</italic>
<volume>426</volume>
<fpage>517</fpage>–<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1038/nature02196</pub-id>
<pub-id pub-id-type="pmid">14654832</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coccia</surname><given-names>E. M.</given-names></name><name><surname>Stellacci</surname><given-names>E.</given-names></name><name><surname>Marziali</surname><given-names>G.</given-names></name><name><surname>Weiss</surname><given-names>G.</given-names></name><name><surname>Battistini</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation.</article-title>
<source/><italic>Int. Immunol.</italic>
<volume>12</volume>
<fpage>977</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/12.7.977</pub-id>
<pub-id pub-id-type="pmid">10882409</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corominas</surname><given-names>R.</given-names></name><name><surname>Ribases</surname><given-names>M.</given-names></name><name><surname>Camiña</surname><given-names>M.</given-names></name><name><surname>Cuenca-León</surname><given-names>E.</given-names></name><name><surname>Pardo</surname><given-names>J.</given-names></name><name><surname>Boronat</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Two-stage case-control association study of dopamine-related genes and migraine.</article-title>
<source/><italic>BMC Med. Genet.</italic>
<volume>10</volume>:<issue>95</issue>. <pub-id pub-id-type="doi">10.1186/1471-2350-10-95</pub-id>
<pub-id pub-id-type="pmid">19772578</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coskun</surname><given-names>S.</given-names></name><name><surname>Varol</surname><given-names>S.</given-names></name><name><surname>Ozdemir</surname><given-names>H. H.</given-names></name><name><surname>Agacayak</surname><given-names>E.</given-names></name><name><surname>Aydın</surname><given-names>B.</given-names></name><name><surname>Kapan</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine.</article-title>
<source/><italic>Neuropsychiatr. Dis. Treat.</italic>
<volume>12</volume>
<fpage>1779</fpage>–<lpage>1785</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S108814</pub-id>
<pub-id pub-id-type="pmid">27486327</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costigan</surname><given-names>M.</given-names></name><name><surname>Belfer</surname><given-names>I.</given-names></name><name><surname>Griffin</surname><given-names>R. S.</given-names></name><name><surname>Dai</surname><given-names>F.</given-names></name><name><surname>Barrett</surname><given-names>L. B.</given-names></name><name><surname>Coppola</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.</article-title>
<source/><italic>Brain</italic>
<volume>133</volume>
<fpage>2519</fpage>–<lpage>2527</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awq195</pub-id>
<pub-id pub-id-type="pmid">20724292</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyle</surname><given-names>J. T.</given-names></name><name><surname>Tsai</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia.</article-title>
<source/><italic>Int. Rev. Neurobiol.</italic>
<volume>59</volume>
<fpage>491</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7742(04)59019-0</pub-id><pub-id pub-id-type="pmid">15006500</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crock</surname><given-names>L. W.</given-names></name><name><surname>Stemler</surname><given-names>K. M.</given-names></name><name><surname>Song</surname><given-names>D. G.</given-names></name><name><surname>Abbosh</surname><given-names>P.</given-names></name><name><surname>Vogt</surname><given-names>S. K.</given-names></name><name><surname>Qiu</surname><given-names>C. S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>8</volume>:<issue>20</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-8-20</pub-id>
<pub-id pub-id-type="pmid">22449017</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila-Fajardo</surname><given-names>C. L.</given-names></name><name><surname>Marquez</surname><given-names>A.</given-names></name><name><surname>Pascual-Salcedo</surname><given-names>D.</given-names></name><name><surname>Moreno Ramos</surname><given-names>M. J.</given-names></name><name><surname>Garcia-Portales</surname><given-names>R.</given-names></name><name><surname>Magro</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome.</article-title>
<source/><italic>Pharmacogenet. Genom.</italic>
<volume>24</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/FPC.0000000000000013</pub-id>
<pub-id pub-id-type="pmid">24253594</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>C.</given-names></name><name><surname>Rappa</surname><given-names>A. G.</given-names></name><name><surname>Gragnano</surname><given-names>G.</given-names></name><name><surname>Malapelle</surname><given-names>U.</given-names></name><name><surname>Troncone</surname><given-names>G.</given-names></name><name><surname>Barberis</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.</article-title>
<source/><italic>J. Clin. Pathol.</italic>
<volume>71</volume>
<fpage>745</fpage>–<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1136/jclinpath-2018-205197</pub-id>
<pub-id pub-id-type="pmid">29798838</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Rooij</surname><given-names>A. M.</given-names></name><name><surname>Florencia Gosso</surname><given-names>M.</given-names></name><name><surname>Haasnoot</surname><given-names>G. W.</given-names></name><name><surname>Marinus</surname><given-names>J.</given-names></name><name><surname>Verduijn</surname><given-names>W.</given-names></name><name><surname>Claas</surname><given-names>F. H.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>HLA-B62 and HLA-DQ8 are associated with complex regional pain syndrome with fixed dystonia.</article-title>
<source/><italic>Pain</italic>
<volume>145</volume>
<fpage>82</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2009.05.015</pub-id>
<pub-id pub-id-type="pmid">19523767</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deakin</surname><given-names>A. M.</given-names></name><name><surname>Payne</surname><given-names>A. N.</given-names></name><name><surname>Whittle</surname><given-names>B. J.</given-names></name><name><surname>Moncada</surname><given-names>S.</given-names></name></person-group> (<year>1995</year>). <article-title>The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma.</article-title>
<source/><italic>Cytokine</italic>
<volume>7</volume>
<fpage>408</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1006/cyto.1995.0056</pub-id>
<pub-id pub-id-type="pmid">7578978</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diatchenko</surname><given-names>L.</given-names></name><name><surname>Anderson</surname><given-names>A. D.</given-names></name><name><surname>Slade</surname><given-names>G. D.</given-names></name><name><surname>Fillingim</surname><given-names>R. B.</given-names></name><name><surname>Shabalina</surname><given-names>S. A.</given-names></name><name><surname>Higgins</surname><given-names>T. J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>141B</volume>
<fpage>449</fpage>–<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30324</pub-id>
<pub-id pub-id-type="pmid">16741943</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diatchenko</surname><given-names>L.</given-names></name><name><surname>Slade</surname><given-names>G. D.</given-names></name><name><surname>Nackley</surname><given-names>A. G.</given-names></name><name><surname>Bhalang</surname><given-names>K.</given-names></name><name><surname>Sigurdsson</surname><given-names>A.</given-names></name><name><surname>Belfer</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Genetic basis for individual variations in pain perception and the development of a chronic pain condition.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>14</volume>
<fpage>135</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi013</pub-id>
<pub-id pub-id-type="pmid">15537663</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>C. A.</given-names></name></person-group> (<year>1994</year>). <article-title>The biological properties of interleukin-1.</article-title>
<source/><italic>Eur. Cytokine Netw.</italic>
<volume>5</volume>
<fpage>517</fpage>–<lpage>531</lpage>.<pub-id pub-id-type="pmid">7727685</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dineley</surname><given-names>K. T.</given-names></name><name><surname>Pandya</surname><given-names>A. A.</given-names></name><name><surname>Yakel</surname><given-names>J. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Nicotinic ACh receptors as therapeutic targets in CNS disorders.</article-title>
<source/><italic>Trends Pharmacol. Sci.</italic>
<volume>36</volume>
<fpage>96</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2014.12.002</pub-id>
<pub-id pub-id-type="pmid">25639674</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Mello</surname><given-names>R.</given-names></name><name><surname>Dickenson</surname><given-names>A. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Spinal cord mechanisms of pain.</article-title>
<source/><italic>Br. J. Anaesth.</italic>
<volume>101</volume>
<fpage>8</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1093/bja/aen088</pub-id>
<pub-id pub-id-type="pmid">18417503</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Kirchhof</surname><given-names>A.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic diagnostics of functional variants of the human dopamine D2 receptor gene.</article-title>
<source/><italic>Psychiatr. Genet.</italic>
<volume>19</volume>
<fpage>259</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32832d0941</pub-id>
<pub-id pub-id-type="pmid">19512960</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Küsener</surname><given-names>N.</given-names></name><name><surname>Flühr</surname><given-names>K.</given-names></name><name><surname>Neddermeyer</surname><given-names>T. J.</given-names></name><name><surname>Schneider</surname><given-names>G.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Effect sizes in experimental pain produced by gender, genetic variants and sensitization procedures.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e17724</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0017724</pub-id>
<pub-id pub-id-type="pmid">21423693</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>C. A.</given-names></name><name><surname>Kalliomaki</surname><given-names>M.</given-names></name><name><surname>Gunnarsson</surname><given-names>U.</given-names></name><name><surname>Moen</surname><given-names>A.</given-names></name><name><surname>Sandblom</surname><given-names>G.</given-names></name><name><surname>Kockum</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The DQB1 <sup>∗</sup>03:02 HLA haplotype is associated with increased risk of chronic pain after inguinal hernia surgery and lumbar disc herniation.</article-title>
<source/><italic>Pain</italic>
<volume>154</volume>
<fpage>427</fpage>–<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2012.12.003</pub-id>
<pub-id pub-id-type="pmid">23318129</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>G.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ying</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The effect of SCN9A variation on basal pain sensitivity in the general population: an experimental study in young women.</article-title>
<source/><italic>J. Pain</italic>
<volume>16</volume>
<fpage>971</fpage>–<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2015.06.011</pub-id>
<pub-id pub-id-type="pmid">26168879</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dupont</surname><given-names>B.</given-names></name><name><surname>Ceppellini</surname><given-names>R.</given-names></name></person-group> (<year>1989</year>). <source/><italic>Immunobiology of HLA.</italic>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>.</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>S.</given-names></name><name><surname>Gangopadhyay</surname><given-names>P. K.</given-names></name><name><surname>Sinha</surname><given-names>S.</given-names></name><name><surname>Chatterjee</surname><given-names>A.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Rajamma</surname><given-names>U.</given-names></name></person-group> (<year>2011</year>). <article-title>An association analysis of reelin gene (RELN) polymorphisms with childhood epilepsy in eastern Indian population from West Bengal.</article-title>
<source/><italic>Cell. Mol. Neurobiol.</italic>
<volume>31</volume>
<fpage>45</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-010-9551-7</pub-id>
<pub-id pub-id-type="pmid">20697953</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dziedziejko</surname><given-names>V.</given-names></name><name><surname>Kurzawski</surname><given-names>M.</given-names></name><name><surname>Safranow</surname><given-names>K.</given-names></name><name><surname>Chlubek</surname><given-names>D.</given-names></name><name><surname>Pawlik</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide.</article-title>
<source/><italic>Pharmacogenomics</italic>
<volume>12</volume>
<fpage>41</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.2217/pgs.10.164</pub-id>
<pub-id pub-id-type="pmid">21174621</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>R. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Genetic predictors of acute and chronic pain.</article-title>
<source/><italic>Curr. Rheumatol. Rep.</italic>
<volume>8</volume>
<fpage>411</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1007/s11926-006-0034-2</pub-id><pub-id pub-id-type="pmid">17092439</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emigh</surname><given-names>T. H.</given-names></name></person-group> (<year>1980</year>). <article-title>A comparison of tests for hardy-weinberg equilibrium.</article-title>
<source/><italic>Biometrics</italic>
<volume>36</volume>
<fpage>627</fpage>–<lpage>642</lpage>. <pub-id pub-id-type="doi">10.2307/2556115</pub-id><pub-id pub-id-type="pmid">25856832</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ersig</surname><given-names>A. L.</given-names></name><name><surname>Schutte</surname><given-names>D. L.</given-names></name><name><surname>Standley</surname><given-names>J.</given-names></name><name><surname>Leslie</surname><given-names>E.</given-names></name><name><surname>Zimmerman</surname><given-names>B.</given-names></name><name><surname>Kleiber</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Relationship of genetic variants with procedural pain, anxiety, and distress in children.</article-title>
<source/><italic>Biol. Res. Nurs.</italic>
<volume>19</volume>
<fpage>339</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1177/1099800417692878</pub-id>
<pub-id pub-id-type="pmid">28413930</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskola</surname><given-names>P. J.</given-names></name><name><surname>Kjaer</surname><given-names>P.</given-names></name><name><surname>Daavittila</surname><given-names>I. M.</given-names></name><name><surname>Solovieva</surname><given-names>S.</given-names></name><name><surname>Okuloff</surname><given-names>A.</given-names></name><name><surname>Sorensen</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Genetic risk factors of disc degeneration among 12-14-year-old danish children: a population study.</article-title>
<source/><italic>Int. J. Mol. Epidemiol. Genet.</italic>
<volume>1</volume>
<fpage>158</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="pmid">21537388</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Egan</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic factors in intervertebral disc degeneration.</article-title>
<source/><italic>Genes Dis.</italic>
<volume>3</volume>
<fpage>178</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.gendis.2016.04.005</pub-id>
<pub-id pub-id-type="pmid">27617275</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Bian</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).</article-title>
<source/><italic>Gene</italic>
<volume>529</volume>
<fpage>296</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2013.07.019</pub-id>
<pub-id pub-id-type="pmid">23939469</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillingim</surname><given-names>R. B.</given-names></name><name><surname>Wallace</surname><given-names>M. R.</given-names></name><name><surname>Herbstman</surname><given-names>D. M.</given-names></name><name><surname>Ribeiro-Dasilva</surname><given-names>M.</given-names></name><name><surname>Staud</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Genetic contributions to pain: a review of findings in humans.</article-title>
<source/><italic>Oral Dis.</italic>
<volume>14</volume>
<fpage>673</fpage>–<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-0825.2008.01458.x</pub-id>
<pub-id pub-id-type="pmid">19193196</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florio</surname><given-names>S. K.</given-names></name><name><surname>Loh</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>S. M.</given-names></name><name><surname>Iwamaye</surname><given-names>A. E.</given-names></name><name><surname>Kitto</surname><given-names>K. F.</given-names></name><name><surname>Fowler</surname><given-names>K. W.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>158</volume>
<fpage>494</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00300.x</pub-id>
<pub-id pub-id-type="pmid">19732061</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franchimont</surname><given-names>D.</given-names></name><name><surname>Martens</surname><given-names>H.</given-names></name><name><surname>Hagelstein</surname><given-names>M. T.</given-names></name><name><surname>Louis</surname><given-names>E.</given-names></name><name><surname>Dewe</surname><given-names>W.</given-names></name><name><surname>Chrousos</surname><given-names>G. P.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor.</article-title>
<source/><italic>J. Clin. Endocrinol. Metab.</italic>
<volume>84</volume>
<fpage>2834</fpage>–<lpage>2839</lpage>. <pub-id pub-id-type="pmid">10443688</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridovich</surname><given-names>I.</given-names></name></person-group> (<year>1978</year>). <article-title>The biology of oxygen radicals.</article-title>
<source/><italic>Science</italic>
<volume>201</volume>
<fpage>875</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1126/science.210504</pub-id><pub-id pub-id-type="pmid">210504</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>T.</given-names></name><name><surname>Ota</surname><given-names>M.</given-names></name><name><surname>Hori</surname><given-names>H.</given-names></name><name><surname>Hattori</surname><given-names>K.</given-names></name><name><surname>Teraishi</surname><given-names>T.</given-names></name><name><surname>Matsuo</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The common functional FKBP5 variant rs1360780 is associated with altered cognitive function in aged individuals.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>4</volume>:<issue>6696</issue>. <pub-id pub-id-type="doi">10.1038/srep06696</pub-id>
<pub-id pub-id-type="pmid">25331639</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadotti</surname><given-names>V. M.</given-names></name><name><surname>Zamponi</surname><given-names>G. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Cellular prion protein protects from inflammatory and neuropathic pain.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>7</volume>:<issue>59</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-7-59</pub-id>
<pub-id pub-id-type="pmid">21843375</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gansner</surname><given-names>E. R.</given-names></name><name><surname>North</surname><given-names>S. C.</given-names></name></person-group> (<year>2000</year>). <article-title>An open graph visualization system and its applications to software engineering.</article-title>
<source/><italic>Softw. Pract. Exp.</italic>
<volume>30</volume>
<fpage>1203</fpage>–<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.1002/1097-024X(200009)30:11&lt;1203::AID-SPE338&gt;3.0.CO;2-N</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garassino</surname><given-names>M. C.</given-names></name><name><surname>Piva</surname><given-names>S.</given-names></name><name><surname>La Verde</surname><given-names>N.</given-names></name><name><surname>Spagnoletti</surname><given-names>I.</given-names></name><name><surname>Iorno</surname><given-names>V.</given-names></name><name><surname>Carbone</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e59981</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059981</pub-id>
<pub-id pub-id-type="pmid">23577077</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garriock</surname><given-names>H. A.</given-names></name><name><surname>Tanowitz</surname><given-names>M.</given-names></name><name><surname>Kraft</surname><given-names>J. B.</given-names></name><name><surname>Dang</surname><given-names>V. C.</given-names></name><name><surname>Peters</surname><given-names>E. J.</given-names></name><name><surname>Jenkins</surname><given-names>G. D.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>167</volume>
<fpage>565</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2009.08081167</pub-id>
<pub-id pub-id-type="pmid">20194481</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gębura</surname><given-names>K.</given-names></name><name><surname>Świerkot</surname><given-names>J.</given-names></name><name><surname>Wysoczańska</surname><given-names>B.</given-names></name><name><surname>Korman</surname><given-names>L.</given-names></name><name><surname>Nowak</surname><given-names>B.</given-names></name><name><surname>Wiland</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Polymorphisms within genes involved in regulation of the NF-κB pathway in patients with rheumatoid arthritis.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>18</volume>
<issue>E1432</issue>. <pub-id pub-id-type="doi">10.3390/ijms18071432</pub-id>
<pub-id pub-id-type="pmid">28677621</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendron</surname><given-names>F. P.</given-names></name><name><surname>Chalimoniuk</surname><given-names>M.</given-names></name><name><surname>Strosznajder</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>S.</given-names></name><name><surname>Gonzalez</surname><given-names>F. A.</given-names></name><name><surname>Weisman</surname><given-names>G. A.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>87</volume>
<fpage>344</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01995.x</pub-id>
<pub-id pub-id-type="pmid">14511112</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgi</surname><given-names>A.</given-names></name><name><surname>Jamra</surname><given-names>R. A.</given-names></name><name><surname>Klein</surname><given-names>K.</given-names></name><name><surname>Villela</surname><given-names>A. W.</given-names></name><name><surname>Schumacher</surname><given-names>J.</given-names></name><name><surname>Becker</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample.</article-title>
<source/><italic>Psychiatr. Genet.</italic>
<volume>17</volume>
<fpage>308</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e3280c1e5fb</pub-id>
<pub-id pub-id-type="pmid">17728671</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>J. E.</given-names></name><name><surname>Ray</surname><given-names>D. W.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of the circadian clock in rheumatoid arthritis.</article-title>
<source/><italic>Arthritis Res. Ther.</italic>
<volume>15</volume>:<issue>205</issue>. <pub-id pub-id-type="doi">10.1186/ar4146</pub-id>
<pub-id pub-id-type="pmid">23427807</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilron</surname><given-names>I.</given-names></name><name><surname>Ghasemlou</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Chronobiology of chronic pain: focus on diurnal rhythmicity of neuropathic pain.</article-title>
<source/><italic>Curr. Opin. Support. Palliat. Care</italic>
<volume>8</volume>
<fpage>429</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1097/SPC.0000000000000085</pub-id>
<pub-id pub-id-type="pmid">25111256</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodin</surname><given-names>B. R.</given-names></name><name><surname>Ness</surname><given-names>T. J.</given-names></name><name><surname>Robbins</surname><given-names>M. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Oxytocin – A multifunctional analgesic for chronic deep tissue pain.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>21</volume>
<fpage>906</fpage>–<lpage>913</lpage>. <pub-id pub-id-type="doi">10.2174/1381612820666141027111843</pub-id><pub-id pub-id-type="pmid">25345612</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodyer</surname><given-names>I. M.</given-names></name><name><surname>Croudace</surname><given-names>T.</given-names></name><name><surname>Dunn</surname><given-names>V.</given-names></name><name><surname>Herbert</surname><given-names>J.</given-names></name><name><surname>Jones</surname><given-names>P. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project.</article-title>
<source/><italic>Int. J. Epidemiol.</italic>
<volume>39</volume>
<fpage>361</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyp173</pub-id>
<pub-id pub-id-type="pmid">19359258</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gramage</surname><given-names>E.</given-names></name><name><surname>Herradon</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic deletion of pleiotrophin leads to disruption of spinal nociceptive transmission: evidence for pleiotrophin modulation of morphine-induced analgesia.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>647</volume>
<fpage>97</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2010.08.029</pub-id>
<pub-id pub-id-type="pmid">20826137</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenbaum</surname><given-names>L.</given-names></name><name><surname>Tegeder</surname><given-names>I.</given-names></name><name><surname>Barhum</surname><given-names>Y.</given-names></name><name><surname>Melamed</surname><given-names>E.</given-names></name><name><surname>Roditi</surname><given-names>Y.</given-names></name><name><surname>Djaldetti</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Contribution of genetic variants to pain susceptibility in Parkinson disease.</article-title>
<source/><italic>Eur. J. Pain</italic>
<volume>16</volume>
<fpage>1243</fpage>–<lpage>1250</lpage>. <pub-id pub-id-type="doi">10.1002/j.1532-2149.2012.00134.x</pub-id>
<pub-id pub-id-type="pmid">22473870</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guerrero</surname><given-names>M.</given-names></name><name><surname>Urbano</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>S. J.</given-names></name><name><surname>Cayanan</surname><given-names>C.</given-names></name><name><surname>Ferguson</surname><given-names>J.</given-names></name><name><surname>Cameron</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>“Optimization and characterization of an opioid kappa receptor (OPRK1) antagonist,” in</article-title>
<source/><italic>Probe Reports from the NIH Molecular Libraries Program.</italic>
<publisher-loc>Bethesda (MD)</publisher-loc>: <publisher-name>National Center for Biotechnology Information (US)</publisher-name>.</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hack</surname><given-names>L. M.</given-names></name><name><surname>Kalsi</surname><given-names>G.</given-names></name><name><surname>Aliev</surname><given-names>F.</given-names></name><name><surname>Kuo</surname><given-names>P.-H.</given-names></name><name><surname>Prescott</surname><given-names>C. A.</given-names></name><name><surname>Patterson</surname><given-names>D. G.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Limited associations of dopamine system genes with alcohol dependence and related traits in the Irish Affected Sib Pair Study of Alcohol Dependence (IASPSAD).</article-title>
<source/><italic>Alcohol. Clin. Exp. Res.</italic>
<volume>35</volume>
<fpage>376</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2010.01353.x</pub-id>
<pub-id pub-id-type="pmid">21083670</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagelberg</surname><given-names>N.</given-names></name><name><surname>Forssell</surname><given-names>H.</given-names></name><name><surname>Aalto</surname><given-names>S.</given-names></name><name><surname>Rinne</surname><given-names>J. O.</given-names></name><name><surname>Scheinin</surname><given-names>H.</given-names></name><name><surname>Taiminen</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Altered dopamine D2 receptor binding in atypical facial pain.</article-title>
<source/><italic>Pain</italic>
<volume>106</volume>
<fpage>43</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3959(03)00275-6</pub-id>
<pub-id pub-id-type="pmid">14581109</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagelberg</surname><given-names>N.</given-names></name><name><surname>Jaaskelainen</surname><given-names>S. K.</given-names></name><name><surname>Martikainen</surname><given-names>I. K.</given-names></name><name><surname>Mansikka</surname><given-names>H.</given-names></name><name><surname>Forssell</surname><given-names>H.</given-names></name><name><surname>Scheinin</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Striatal dopamine D2 receptors in modulation of pain in humans: a review.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>500</volume>
<fpage>187</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2004.07.024</pub-id>
<pub-id pub-id-type="pmid">15464032</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>W.-H.</given-names></name><name><surname>Suh</surname><given-names>J.-S.</given-names></name><name><surname>Cho</surname><given-names>B.-S.</given-names></name></person-group> (<year>2011</year>). <article-title>Linkage and association study of neurotrophins and their receptors as novel susceptibility genes for childhood IgA nephropathy.</article-title>
<source/><italic>Pediatr. Res.</italic>
<volume>69</volume>
<fpage>299</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e31820b9365</pub-id>
<pub-id pub-id-type="pmid">21178826</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haus</surname><given-names>E.</given-names></name><name><surname>Sackett-Lundeen</surname><given-names>L.</given-names></name><name><surname>Smolensky</surname><given-names>M. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications.</article-title>
<source/><italic>Bull. NYU Hosp. Jt. Dis.</italic>
<volume>70(Suppl. 1)</volume>
<fpage>3</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">23259651</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>G.-H.</given-names></name><name><surname>Cai</surname><given-names>W.-K.</given-names></name><name><surname>Zhang</surname><given-names>J.-B.</given-names></name><name><surname>Ma</surname><given-names>C.-Y.</given-names></name><name><surname>Yan</surname><given-names>F.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Associations of polymorphisms in HRH2, HRH3, DAO, and HNMT genes with risk of chronic heart failure.</article-title>
<source/><italic>Biomed. Res. Int.</italic>
<volume>2016</volume>:<issue>1208476</issue>. <pub-id pub-id-type="doi">10.1155/2016/1208476</pub-id>
<pub-id pub-id-type="pmid">26989676</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>A. I.</given-names></name><name><surname>Balogh</surname><given-names>K. N.</given-names></name></person-group> (<year>2012</year>). <article-title>Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse.</article-title>
<source/><italic>Subst. Abuse Rehabil.</italic>
<volume>3</volume>
<fpage>49</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.2147/SAR.S25864</pub-id>
<pub-id pub-id-type="pmid">22933845</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillard</surname><given-names>C. J.</given-names></name><name><surname>Weinlander</surname><given-names>K. M.</given-names></name><name><surname>Stuhr</surname><given-names>K. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.</article-title>
<source/><italic>Neuroscience</italic>
<volume>204</volume>
<fpage>207</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.11.020</pub-id>
<pub-id pub-id-type="pmid">22123166</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>A. M.</given-names></name><name><surname>Tang</surname><given-names>N. L.</given-names></name><name><surname>Cheung</surname><given-names>B. K.</given-names></name><name><surname>Stadlin</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Dopamine receptor D4 gene -521C/T polymorphism is associated with opioid dependence through cold-pain responses.</article-title>
<source/><italic>Ann. N. Y. Acad. Sci.</italic>
<volume>1139</volume>
<fpage>20</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1432.054</pub-id>
<pub-id pub-id-type="pmid">18991844</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hocking</surname><given-names>L. J.</given-names></name><name><surname>Smith</surname><given-names>B. H.</given-names></name><name><surname>Jones</surname><given-names>G. T.</given-names></name><name><surname>Reid</surname><given-names>D. M.</given-names></name><name><surname>Strachan</surname><given-names>D. P.</given-names></name><name><surname>Macfarlane</surname><given-names>G. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort study.</article-title>
<source/><italic>Pain</italic>
<volume>149</volume>
<fpage>143</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2010.01.023</pub-id>
<pub-id pub-id-type="pmid">20167428</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogart</surname><given-names>A.</given-names></name><name><surname>Nagarajan</surname><given-names>R. P.</given-names></name><name><surname>Patzel</surname><given-names>K. A.</given-names></name><name><surname>Yasui</surname><given-names>D. H.</given-names></name><name><surname>Lasalle</surname><given-names>J. M.</given-names></name></person-group> (<year>2007</year>). <article-title>15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>16</volume>
<fpage>691</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm014</pub-id>
<pub-id pub-id-type="pmid">17339270</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hohmann</surname><given-names>S. W.</given-names></name><name><surname>Angioni</surname><given-names>C.</given-names></name><name><surname>Tunaru</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Woolf</surname><given-names>C. J.</given-names></name><name><surname>Offermanns</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>446</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-00591-0</pub-id>
<pub-id pub-id-type="pmid">28348394</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hough</surname><given-names>L. B.</given-names></name><name><surname>Rice</surname><given-names>F. L.</given-names></name></person-group> (<year>2011</year>). <article-title>H3 receptors and pain modulation: peripheral, spinal, and brain interactions.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>336</volume>
<fpage>30</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.110.171264</pub-id>
<pub-id pub-id-type="pmid">20864501</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Pan</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Higher prevalence of migraine in essential tremor: a case-control study.</article-title>
<source/><italic>Cephalalgia</italic>
<volume>34</volume>
<fpage>1142</fpage>–<lpage>1149</lpage>. <pub-id pub-id-type="doi">10.1177/0333102414531153</pub-id>
<pub-id pub-id-type="pmid">24728302</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Adachi</surname><given-names>N.</given-names></name><name><surname>Nagaro</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Arai</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Histaminergic involvement in neuropathic pain produced by partial ligation of the sciatic nerve in rats.</article-title>
<source/><italic>Reg. Anesth Pain. Med.</italic>
<volume>32</volume>
<fpage>124</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1097/00115550-200703000-00006</pub-id>
<pub-id pub-id-type="pmid">17350523</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulse</surname><given-names>R. P.</given-names></name><name><surname>Donaldson</surname><given-names>L. F.</given-names></name><name><surname>Wynick</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Peripheral galanin receptor 2 as a target for the modulation of pain.</article-title>
<source/><italic>Pain Res. Treat.</italic>
<volume>2012</volume>
<issue>545386</issue>. <pub-id pub-id-type="doi">10.1155/2012/545386</pub-id>
<pub-id pub-id-type="pmid">22315681</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchinson</surname><given-names>M. R.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Shridhar</surname><given-names>M.</given-names></name><name><surname>Evans</surname><given-names>J. H.</given-names></name><name><surname>Buchanan</surname><given-names>M. M.</given-names></name><name><surname>Zhao</surname><given-names>T. X.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Evidence that opioids may have toll-like receptor 4 and MD-2 effects.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>24</volume>
<fpage>83</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.08.004</pub-id>
<pub-id pub-id-type="pmid">19679181</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>I. C.</given-names></name><name><surname>Park</surname><given-names>J. Y.</given-names></name><name><surname>Myung</surname><given-names>S. K.</given-names></name><name><surname>Ahn</surname><given-names>H. Y.</given-names></name><name><surname>Fukuda</surname><given-names>K.</given-names></name><name><surname>Liao</surname><given-names>Q.</given-names></name></person-group> (<year>2014</year>). <article-title>OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis.</article-title>
<source/><italic>Anesthesiology</italic>
<volume>121</volume>
<fpage>825</fpage>–<lpage>834</lpage>. <pub-id pub-id-type="doi">10.1097/ALN.0000000000000405</pub-id>
<pub-id pub-id-type="pmid">25102313</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ide</surname><given-names>S.</given-names></name><name><surname>Nishizawa</surname><given-names>D.</given-names></name><name><surname>Fukuda</surname><given-names>K.-I.</given-names></name><name><surname>Kasai</surname><given-names>S.</given-names></name><name><surname>Hasegawa</surname><given-names>J.</given-names></name><name><surname>Hayashida</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Haplotypes of P2RX7 gene polymorphisms are associated with both cold pain sensitivity and analgesic effect of fentanyl.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>10</volume>:<issue>75</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-10-75</pub-id>
<pub-id pub-id-type="pmid">25472448</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaaskelainen</surname><given-names>S. K.</given-names></name><name><surname>Lindholm</surname><given-names>P.</given-names></name><name><surname>Valmunen</surname><given-names>T.</given-names></name><name><surname>Pesonen</surname><given-names>U.</given-names></name><name><surname>Taiminen</surname><given-names>T.</given-names></name><name><surname>Virtanen</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation.</article-title>
<source/><italic>Pain</italic>
<volume>155</volume>
<fpage>2180</fpage>–<lpage>2187</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2014.08.029</pub-id>
<pub-id pub-id-type="pmid">25180011</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Human pain and genetics: some basics.</article-title>
<source/><italic>Br. J. Pain</italic>
<volume>7</volume>
<fpage>171</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1177/2049463713506408</pub-id>
<pub-id pub-id-type="pmid">26516521</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayamanne</surname><given-names>A.</given-names></name><name><surname>Greenwood</surname><given-names>R.</given-names></name><name><surname>Mitchell</surname><given-names>V. A.</given-names></name><name><surname>Aslan</surname><given-names>S.</given-names></name><name><surname>Piomelli</surname><given-names>D.</given-names></name><name><surname>Vaughan</surname><given-names>C. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>147</volume>
<fpage>281</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706510</pub-id>
<pub-id pub-id-type="pmid">16331291</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhun</surname><given-names>E.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Molokie</surname><given-names>R. E.</given-names></name><name><surname>Wilkie</surname><given-names>D. J.</given-names></name><name><surname>Wang</surname><given-names>Z. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease.</article-title>
<source/><italic>Anesth. Analg.</italic>
<volume>119</volume>
<fpage>1201</fpage>–<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1213/ANE.0000000000000382</pub-id>
<pub-id pub-id-type="pmid">25102390</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhun</surname><given-names>E. H.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Mack</surname><given-names>A. K.</given-names></name><name><surname>Wilkie</surname><given-names>D. J.</given-names></name><name><surname>Molokie</surname><given-names>R. E.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell disease.</article-title>
<source/><italic>Pharmacogenomics</italic>
<volume>16</volume>
<fpage>1795</fpage>–<lpage>1806</lpage>. <pub-id pub-id-type="doi">10.2217/pgs.15.126</pub-id>
<pub-id pub-id-type="pmid">26555434</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurečeková</surname><given-names>J.</given-names></name><name><surname>Babušíková</surname><given-names>E.</given-names></name><name><surname>Kmet’ová</surname><given-names>M.</given-names></name><name><surname>Kliment</surname><given-names>J.</given-names></name><name><surname>Dobrota</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Estrogen receptor alpha polymorphisms and the risk of prostate cancer development.</article-title>
<source/><italic>J. Cancer Res. Clin. Oncol.</italic>
<volume>141</volume>
<fpage>1963</fpage>–<lpage>1971</lpage>. <pub-id pub-id-type="doi">10.1007/s00432-015-1966-6</pub-id>
<pub-id pub-id-type="pmid">25828708</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katusic</surname><given-names>Z. S.</given-names></name><name><surname>Stelter</surname><given-names>A.</given-names></name><name><surname>Milstien</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells.</article-title>
<source/><italic>Arterioscler. Thromb. Vasc. Biol.</italic>
<volume>18</volume>
<fpage>27</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1161/01.ATV.18.1.27</pub-id>
<pub-id pub-id-type="pmid">9445252</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaunisto</surname><given-names>M. A.</given-names></name><name><surname>Jokela</surname><given-names>R.</given-names></name><name><surname>Tallgren</surname><given-names>M.</given-names></name><name><surname>Kambur</surname><given-names>O.</given-names></name><name><surname>Tikkanen</surname><given-names>E.</given-names></name><name><surname>Tasmuth</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Pain in 1000 women treated for breast cancer: a prospective study of pain sensitivity and postoperative pain.</article-title>
<source/><italic>Anesthesiology</italic>
<volume>119</volume>
<fpage>1410</fpage>–<lpage>1421</lpage>. <pub-id pub-id-type="doi">10.1097/ALN.0000000000000012</pub-id>
<pub-id pub-id-type="pmid">24343286</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname><given-names>H.</given-names></name><name><surname>Sereika</surname><given-names>S. M.</given-names></name><name><surname>Dai</surname><given-names>F.</given-names></name><name><surname>Alexander</surname><given-names>S.</given-names></name><name><surname>Conley</surname><given-names>Y.</given-names></name><name><surname>Gruen</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>OPRM1 and COMT gene-gene interaction is associated with postoperative pain and opioid consumption after orthopedic trauma.</article-title>
<source/><italic>Biol. Res. Nurs.</italic>
<volume>19</volume>
<fpage>170</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1177/1099800416680474</pub-id>
<pub-id pub-id-type="pmid">27903758</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Rowan</surname><given-names>J.</given-names></name><name><surname>Brahim</surname><given-names>J.</given-names></name><name><surname>Dionne</surname><given-names>R. A.</given-names></name></person-group> (<year>2006a</year>). <article-title>Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>2</volume>:<issue>24</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-2-24</pub-id>
<pub-id pub-id-type="pmid">16848906</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Mittal</surname><given-names>D. P.</given-names></name><name><surname>Iadarola</surname><given-names>M. J.</given-names></name><name><surname>Dionne</surname><given-names>R. A.</given-names></name></person-group> (<year>2006b</year>). <article-title>Genetic predictors for acute experimental cold and heat pain sensitivity in humans.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>43</volume>:<issue>e40</issue>. <pub-id pub-id-type="doi">10.1136/jmg.2005.036079</pub-id>
<pub-id pub-id-type="pmid">16882734</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Neubert</surname><given-names>J. K.</given-names></name><name><surname>San Miguel</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Krishnaraju</surname><given-names>R. K.</given-names></name><name><surname>Iadarola</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament.</article-title>
<source/><italic>Pain</italic>
<volume>109</volume>
<fpage>488</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2004.02.027</pub-id>
<pub-id pub-id-type="pmid">15157710</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Phospholipids: a neuroinflammation emerging target.</article-title>
<source/><italic>Nat. Chem. Biol.</italic>
<volume>11</volume>
<fpage>99</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1740</pub-id>
<pub-id pub-id-type="pmid">25602728</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. I.</given-names></name><name><surname>Kim</surname><given-names>J.-W.</given-names></name><name><surname>Park</surname><given-names>J.-E.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>S.-B.</given-names></name><name><surname>Han</surname><given-names>D. H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder.</article-title>
<source/><italic>J. Psychopharmacol.</italic>
<volume>31</volume>
<fpage>1070</fpage>–<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1177/0269881116667707</pub-id>
<pub-id pub-id-type="pmid">27624150</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>C. J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Kilfoyle</surname><given-names>D. H.</given-names></name><name><surname>Sandroni</surname><given-names>P.</given-names></name><name><surname>Davis</surname><given-names>M. D.</given-names></name><name><surname>Gavrilova</surname><given-names>R. H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>84</volume>
<fpage>386</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-303719</pub-id>
<pub-id pub-id-type="pmid">23129781</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klepstad</surname><given-names>P.</given-names></name><name><surname>Rakvag</surname><given-names>T. T.</given-names></name><name><surname>Kaasa</surname><given-names>S.</given-names></name><name><surname>Holthe</surname><given-names>M.</given-names></name><name><surname>Dale</surname><given-names>O.</given-names></name><name><surname>Borchgrevink</surname><given-names>P. C.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The 118 A &gt; G polymorphism in the human micro-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.</article-title>
<source/><italic>Acta Anaesthesiol. Scand.</italic>
<volume>48</volume>
<fpage>1232</fpage>–<lpage>1239</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-6576.2004.00517.x</pub-id>
<pub-id pub-id-type="pmid">15504181</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>S. W.</given-names></name><name><surname>Vadakkan</surname><given-names>K. I.</given-names></name><name><surname>Ao</surname><given-names>H.</given-names></name><name><surname>Gallitano-Mendel</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>F.</given-names></name><name><surname>Milbrandt</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Selective contribution of Egr1 (zif/268) to persistent inflammatory pain.</article-title>
<source/><italic>J. Pain</italic>
<volume>6</volume>
<fpage>12</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2004.10.001</pub-id>
<pub-id pub-id-type="pmid">15629414</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kooloos</surname><given-names>W. M.</given-names></name><name><surname>Wessels</surname><given-names>J. A.</given-names></name><name><surname>Van Der Straaten</surname><given-names>T.</given-names></name><name><surname>Allaart</surname><given-names>C. F.</given-names></name><name><surname>Huizinga</surname><given-names>T. W.</given-names></name><name><surname>Guchelaar</surname><given-names>H. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.</article-title>
<source/><italic>Pharmacogenomics</italic>
<volume>11</volume>
<fpage>163</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.2217/pgs.09.139</pub-id>
<pub-id pub-id-type="pmid">20136356</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kringel</surname><given-names>D.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Pain research funding by the european union seventh framework programme.</article-title>
<source/><italic>Eur. J. Pain</italic>
<volume>19</volume>
<fpage>595</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1002/ejp.690</pub-id>
<pub-id pub-id-type="pmid">25857368</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kringel</surname><given-names>D.</given-names></name><name><surname>Sisignano</surname><given-names>M.</given-names></name><name><surname>Zinn</surname><given-names>S.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Next-generation sequencing of the human <italic>TRPV1</italic> gene and the regulating co-players <italic>LTB4R</italic> and <italic>LTB4R2</italic> based on a custom AmpliSeq panel.</article-title>
<source/><italic>PLoS One</italic>
<volume>12</volume>:<issue>e0180116</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0180116</pub-id>
<pub-id pub-id-type="pmid">28658281</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Chakraborty</surname><given-names>J.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>36</volume>
<fpage>225</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2011.10.018</pub-id>
<pub-id pub-id-type="pmid">22138325</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Mahal</surname><given-names>B. A.</given-names></name></person-group> (<year>2012</year>). <article-title>NGF – The TrkA to successful pain treatment.</article-title>
<source/><italic>J. Pain Res.</italic>
<volume>5</volume>
<fpage>279</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.2147/JPR.S33408</pub-id>
<pub-id pub-id-type="pmid">23028238</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurita</surname><given-names>G. P.</given-names></name><name><surname>Ekholm</surname><given-names>O.</given-names></name><name><surname>Kaasa</surname><given-names>S.</given-names></name><name><surname>Klepstad</surname><given-names>P.</given-names></name><name><surname>Skorpen</surname><given-names>F.</given-names></name><name><surname>Sjøgren</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.</article-title>
<source/><italic>Brain Behav.</italic>
<volume>6</volume>:<issue>e00471</issue>. <pub-id pub-id-type="doi">10.1002/brb3.471</pub-id>
<pub-id pub-id-type="pmid">27247849</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>H. J.</given-names></name><name><surname>Jang</surname><given-names>W.-C.</given-names></name><name><surname>Lim</surname><given-names>M. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Association between RELN gene polymorphisms and attention deficit hyperactivity disorder in korean children.</article-title>
<source/><italic>Psychiatry Investig.</italic>
<volume>13</volume>
<fpage>210</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.4306/pi.2016.13.2.210</pub-id>
<pub-id pub-id-type="pmid">27081382</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacroix-Fralish</surname><given-names>M. L.</given-names></name><name><surname>Ledoux</surname><given-names>J. B.</given-names></name><name><surname>Mogil</surname><given-names>J. S.</given-names></name></person-group> (<year>2007</year>). <article-title>The pain genes database: an interactive web browser of pain-related transgenic knockout studies.</article-title>
<source/><italic>Pain</italic>
<volume>131</volume>
<fpage>e1</fpage>–<lpage>e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2007.04.041</pub-id>
<pub-id pub-id-type="pmid">17574758</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname><given-names>E. S.</given-names></name><name><surname>Linton</surname><given-names>L. M.</given-names></name><name><surname>Birren</surname><given-names>B.</given-names></name><name><surname>Nusbaum</surname><given-names>C.</given-names></name><name><surname>Zody</surname><given-names>M. C.</given-names></name><name><surname>Baldwin</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Initial sequencing and analysis of the human genome.</article-title>
<source/><italic>Nature</italic>
<volume>409</volume>
<fpage>860</fpage>–<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1038/35057062</pub-id>
<pub-id pub-id-type="pmid">11237011</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>P. Y.</given-names></name><name><surname>Reggio</surname><given-names>P. H.</given-names></name><name><surname>Loh</surname><given-names>H. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Opioid receptors: toward separation of analgesic from undesirable effects.</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>38</volume>
<fpage>275</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2013.03.003</pub-id>
<pub-id pub-id-type="pmid">23598157</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledergerber</surname><given-names>C.</given-names></name><name><surname>Dessimoz</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Base-calling for next-generation sequencing platforms.</article-title>
<source/><italic>Brief. Bioinform.</italic>
<volume>12</volume>
<fpage>489</fpage>–<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbq077</pub-id>
<pub-id pub-id-type="pmid">21245079</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M.</given-names></name><name><surname>Tracey</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Neuro-genetics of persistent pain.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>23</volume>
<fpage>127</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2012.11.007</pub-id>
<pub-id pub-id-type="pmid">23228429</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>L.</given-names></name><name><surname>Cahill</surname><given-names>C. M.</given-names></name></person-group> (<year>2010</year>). <article-title>TNF-alpha and neuropathic pain–a review.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>7</volume>:<issue>27</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-7-27</pub-id>
<pub-id pub-id-type="pmid">20398373</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J. Y.</given-names></name><name><surname>Tao</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>X. X.</given-names></name><name><surname>Tan</surname><given-names>Y. Z.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Polymorphic variations in manganese superoxide dismutase (MnSOD) and endothelial nitric oxide synthase (eNOS) genes contribute to the development of type 2 diabetes mellitus in the Chinese Han population.</article-title>
<source/><italic>Genet. Mol. Res.</italic>
<volume>14</volume>
<fpage>12993</fpage>–<lpage>13002</lpage>. <pub-id pub-id-type="doi">10.4238/2015.October.21.20</pub-id>
<pub-id pub-id-type="pmid">26505452</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Dai</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A Meta-Analysis of the association between ESR1 genetic variants and the risk of breast cancer.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0153314</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0153314</pub-id>
<pub-id pub-id-type="pmid">29342211</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.-H.</given-names></name><name><surname>Chaudhuri</surname><given-names>K. R.</given-names></name><name><surname>Fan</surname><given-names>J.-Y.</given-names></name><name><surname>Ko</surname><given-names>C.-I.</given-names></name><name><surname>Rizos</surname><given-names>A.</given-names></name><name><surname>Chang</surname><given-names>C.-W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>6306</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-06782-z</pub-id>
<pub-id pub-id-type="pmid">28740224</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindstedt</surname><given-names>F.</given-names></name><name><surname>Karshikoff</surname><given-names>B.</given-names></name><name><surname>Schalling</surname><given-names>M.</given-names></name><name><surname>Olgart Hoglund</surname><given-names>C.</given-names></name><name><surname>Ingvar</surname><given-names>M.</given-names></name><name><surname>Lekander</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Serotonin-1A receptor polymorphism (rs6295) associated with thermal pain perception.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e43221</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0043221</pub-id>
<pub-id pub-id-type="pmid">22952650</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>C.</given-names></name><name><surname>Kringel</surname><given-names>D.</given-names></name><name><surname>Ultsch</surname><given-names>A.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Computational functional genomics-based approaches in analgesic drug discovery and repurposing.</article-title>
<source/><italic>Pharmacogenomics</italic>
<volume>19</volume>
<fpage>783</fpage>–<lpage>797</lpage>. <pub-id pub-id-type="doi">10.2217/pgs-2018-0036</pub-id><pub-id pub-id-type="pmid">29792109</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>SNPs and haplotypes in the S100B gene reveal association with schizophrenia.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>328</volume>
<fpage>335</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.12.175</pub-id>
<pub-id pub-id-type="pmid">15670788</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. N.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Suo</surname><given-names>Z. W.</given-names></name><name><surname>Xu</surname><given-names>Y. M.</given-names></name><name><surname>Hu</surname><given-names>X. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Fyn kinase-regulated NMDA receptor- and AMPA receptor-dependent pain sensitization in spinal dorsal horn of mice.</article-title>
<source/><italic>Eur. J. Pain</italic>
<volume>18</volume>
<fpage>1120</fpage>–<lpage>1128</lpage>. <pub-id pub-id-type="doi">10.1002/j.1532-2149.2014.00455.x</pub-id>
<pub-id pub-id-type="pmid">24443328</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loggia</surname><given-names>M. L.</given-names></name><name><surname>Chonde</surname><given-names>D. B.</given-names></name><name><surname>Akeju</surname><given-names>O.</given-names></name><name><surname>Arabasz</surname><given-names>G.</given-names></name><name><surname>Catana</surname><given-names>C.</given-names></name><name><surname>Edwards</surname><given-names>R. R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Evidence for brain glial activation in chronic pain patients.</article-title>
<source/><italic>Brain</italic>
<volume>138</volume>
<fpage>604</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awu377</pub-id>
<pub-id pub-id-type="pmid">25582579</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohmann</surname><given-names>K.</given-names></name><name><surname>Klein</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Next generation sequencing and the future of genetic diagnosis.</article-title>
<source/><italic>Neurotherapeutics</italic>
<volume>11</volume>
<fpage>699</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-014-0288-8</pub-id>
<pub-id pub-id-type="pmid">25052068</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loncar</surname><given-names>Z.</given-names></name><name><surname>Curic</surname><given-names>G.</given-names></name><name><surname>Mestrovic</surname><given-names>A. H.</given-names></name><name><surname>Mickovic</surname><given-names>V.</given-names></name><name><surname>Bilic</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Do IL-1B and IL-1RN modulate chronic low back pain in patients with post-traumatic stress disorder?</article-title>
<source/><italic>Collegium Antropol.</italic>
<volume>37</volume>
<fpage>1237</fpage>–<lpage>1244</lpage>. <pub-id pub-id-type="pmid">24611340</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Mogil</surname><given-names>J. S.</given-names></name><name><surname>Arndt</surname><given-names>T.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name><name><surname>Ultsch</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Functional genomics of pain in analgesic drug development and therapy.</article-title>
<source/><italic>Pharmacol. Ther.</italic>
<volume>139</volume>
<fpage>60</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.04.004</pub-id>
<pub-id pub-id-type="pmid">23567662</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Fluhr</surname><given-names>K.</given-names></name><name><surname>Neddermayer</surname><given-names>T.</given-names></name><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name></person-group> (<year>2009a</year>). <article-title>The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain.</article-title>
<source/><italic>Clin. Pharmacol. Ther.</italic>
<volume>85</volume>
<fpage>25</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/clpt.2008.103</pub-id>
<pub-id pub-id-type="pmid">18548001</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name><name><surname>Tegeder</surname><given-names>I.</given-names></name></person-group> (<year>2009b</year>). <article-title>Genetic modulation of the pharmacological treatment of pain.</article-title>
<source/><italic>Pharmacol. Ther.</italic>
<volume>124</volume>
<fpage>168</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2009.06.010</pub-id>
<pub-id pub-id-type="pmid">19615406</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Von Hentig</surname><given-names>N.</given-names></name><name><surname>Freynhagen</surname><given-names>R.</given-names></name><name><surname>Griessinger</surname><given-names>N.</given-names></name><name><surname>Zimmermann</surname><given-names>M.</given-names></name><name><surname>Doehring</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2009c</year>). <article-title>Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.</article-title>
<source/><italic>Pharmacogenet. Genom.</italic>
<volume>19</volume>
<fpage>429</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1097/FPC.0b013e32832b89da</pub-id>
<pub-id pub-id-type="pmid">19514130</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Are mu-opioid receptor polymorphisms important for clinical opioid therapy?</article-title>
<source/><italic>Trends Mol. Med.</italic>
<volume>11</volume>
<fpage>82</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2004.12.006</pub-id>
<pub-id pub-id-type="pmid">15694871</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>A critical appraisal of human genotyping for pain therapy.</article-title>
<source/><italic>Trends Pharmacol. Sci.</italic>
<volume>31</volume>
<fpage>312</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2010.04.002</pub-id>
<pub-id pub-id-type="pmid">20483491</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Klepstad</surname><given-names>P.</given-names></name><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Dale</surname><given-names>O.</given-names></name></person-group> (<year>2010</year>). <article-title>A GTP cyclohydrolase 1 genetic variant delays cancer pain.</article-title>
<source/><italic>Pain</italic>
<volume>148</volume>
<fpage>103</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2009.10.021</pub-id>
<pub-id pub-id-type="pmid">19959292</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Sipilä</surname><given-names>R.</given-names></name><name><surname>Tasmuth</surname><given-names>T.</given-names></name><name><surname>Kringel</surname><given-names>D.</given-names></name><name><surname>Estlander</surname><given-names>A. M.</given-names></name><name><surname>Meretoja</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy.</article-title>
<source/><italic>Breast Cancer Res./Treatment.</italic>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="doi">10.1007/s10549-018-4841-8</pub-id>
<pub-id pub-id-type="pmid">29876695</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Skarke</surname><given-names>C.</given-names></name><name><surname>Grosch</surname><given-names>S.</given-names></name><name><surname>Darimont</surname><given-names>J.</given-names></name><name><surname>Schmidt</surname><given-names>H.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine.</article-title>
<source/><italic>Pharmacogenetics</italic>
<volume>12</volume>
<fpage>3</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/00008571-200201000-00002</pub-id>
<pub-id pub-id-type="pmid">11773859</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lötsch</surname><given-names>J.</given-names></name><name><surname>Stuck</surname><given-names>B.</given-names></name><name><surname>Hummel</surname><given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>The human mu-opioid receptor gene polymorphism 118A &gt; G decreases cortical activation in response to specific nociceptive stimulation.</article-title>
<source/><italic>Behav. Neurosci.</italic>
<volume>120</volume>
<fpage>1218</fpage>–<lpage>1224</lpage>. <pub-id pub-id-type="doi">10.1037/0735-7044.120.6.1218</pub-id>
<pub-id pub-id-type="pmid">17201465</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Lian</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.</article-title>
<source/><italic>Tumour Biol.</italic>
<volume>36</volume>
<fpage>5241</fpage>–<lpage>5247</lpage>. <pub-id pub-id-type="doi">10.1007/s13277-015-3182-z</pub-id>
<pub-id pub-id-type="pmid">25663494</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertens</surname><given-names>O.</given-names></name><name><surname>De Schepper</surname><given-names>S.</given-names></name><name><surname>Vandesompele</surname><given-names>J.</given-names></name><name><surname>Brems</surname><given-names>H.</given-names></name><name><surname>Heyns</surname><given-names>I.</given-names></name><name><surname>Janssens</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>81</volume>
<fpage>243</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1086/519562</pub-id>
<pub-id pub-id-type="pmid">17668375</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>A. R.</given-names></name><name><surname>Farmer</surname><given-names>M. A.</given-names></name><name><surname>Baliki</surname><given-names>M. N.</given-names></name><name><surname>Apkarian</surname><given-names>A. V.</given-names></name></person-group> (<year>2014</year>). <article-title>Chronic pain: the role of learning and brain plasticity.</article-title>
<source/><italic>Restor. Neurol. Neurosci.</italic>
<volume>32</volume>
<fpage>129</fpage>–<lpage>139</lpage>.<pub-id pub-id-type="pmid">23603439</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcos</surname><given-names>M.</given-names></name><name><surname>Pastor</surname><given-names>I.</given-names></name><name><surname>De La Calle</surname><given-names>C.</given-names></name><name><surname>Barrio-Real</surname><given-names>L.</given-names></name><name><surname>Laso</surname><given-names>F.-J.</given-names></name><name><surname>González-Sarmiento</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Cannabinoid receptor 1 gene is associated with alcohol dependence.</article-title>
<source/><italic>Alcohol. Clin. Exp. Res.</italic>
<volume>36</volume>
<fpage>267</fpage>–<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2011.01623.x</pub-id>
<pub-id pub-id-type="pmid">22085192</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martikainen</surname><given-names>I. K.</given-names></name><name><surname>Nuechterlein</surname><given-names>E. B.</given-names></name><name><surname>Pecina</surname><given-names>M.</given-names></name><name><surname>Love</surname><given-names>T. M.</given-names></name><name><surname>Cummiford</surname><given-names>C. M.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>35</volume>
<fpage>9957</fpage>–<lpage>9965</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4605-14.2015</pub-id>
<pub-id pub-id-type="pmid">26156996</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maxwell</surname><given-names>J. R.</given-names></name><name><surname>Potter</surname><given-names>C.</given-names></name><name><surname>Hyrich</surname><given-names>K. L.</given-names></name><name><surname>Barton</surname><given-names>A.</given-names></name><name><surname>Worthington</surname><given-names>J.</given-names></name><name><surname>Isaacs</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>17</volume>
<fpage>3532</fpage>–<lpage>3538</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn245</pub-id>
<pub-id pub-id-type="pmid">18713756</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>A. M.</given-names></name><name><surname>Simen</surname><given-names>A. A.</given-names></name><name><surname>Evans</surname><given-names>K. L.</given-names></name><name><surname>Hall</surname><given-names>J.</given-names></name><name><surname>Macintyre</surname><given-names>D. J.</given-names></name><name><surname>Blackwood</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetic variation in hyperpolarization-activated cyclic nucleotide-gated channels and its relationship with neuroticism, cognition and risk of depression.</article-title>
<source/><italic>Front. Genet.</italic>
<volume>3</volume>:<issue>116</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2012.00116</pub-id>
<pub-id pub-id-type="pmid">22783272</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mead</surname><given-names>S.</given-names></name><name><surname>Poulter</surname><given-names>M.</given-names></name><name><surname>Uphill</surname><given-names>J.</given-names></name><name><surname>Beck</surname><given-names>J.</given-names></name><name><surname>Whitfield</surname><given-names>J.</given-names></name><name><surname>Webb</surname><given-names>T. E. F.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>8</volume>
<fpage>57</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(08)70265-5</pub-id><pub-id pub-id-type="pmid">19081515</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzker</surname><given-names>M. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Sequencing technologies – The next generation.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>11</volume>
<fpage>31</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2626</pub-id>
<pub-id pub-id-type="pmid">19997069</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mill</surname><given-names>J.</given-names></name><name><surname>Kiss</surname><given-names>E.</given-names></name><name><surname>Baji</surname><given-names>I.</given-names></name><name><surname>Kapornai</surname><given-names>K.</given-names></name><name><surname>Daróczy</surname><given-names>G.</given-names></name><name><surname>Vetró</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Association study of the estrogen receptor alpha gene (ESR1) and childhood-onset mood disorders.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>147B</volume>
<fpage>1323</fpage>–<lpage>1326</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30751</pub-id>
<pub-id pub-id-type="pmid">18449864</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milne</surname><given-names>R. L.</given-names></name><name><surname>Burwinkel</surname><given-names>B.</given-names></name><name><surname>Michailidou</surname><given-names>K.</given-names></name><name><surname>Arias-Perez</surname><given-names>J.-I.</given-names></name><name><surname>Zamora</surname><given-names>M. P.</given-names></name><name><surname>Menéndez-Rodríguez</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer association consortium.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>6096</fpage>–<lpage>6111</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu311</pub-id>
<pub-id pub-id-type="pmid">24943594</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>A. K.</given-names></name><name><surname>Crews</surname><given-names>K.</given-names></name><name><surname>Pounds</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Downing</surname><given-names>J. R.</given-names></name><name><surname>Raimondi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study.</article-title>
<source/><italic>Leukemia</italic>
<volume>25</volume>
<fpage>1354</fpage>–<lpage>1356</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2011.74</pub-id>
<pub-id pub-id-type="pmid">21483441</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mocellin</surname><given-names>S.</given-names></name><name><surname>Marincola</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>C. R.</given-names></name><name><surname>Nitti</surname><given-names>D.</given-names></name><name><surname>Lise</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle.</article-title>
<source/><italic>Cytokine Growth. Factor. Rev.</italic>
<volume>15</volume>
<fpage>61</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2003.11.001</pub-id>
<pub-id pub-id-type="pmid">14746814</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogil</surname><given-names>J. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Are we getting anywhere in human pain genetics?</article-title>
<source/><italic>Pain</italic>
<volume>146</volume>
<fpage>231</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2009.07.023</pub-id>
<pub-id pub-id-type="pmid">19679395</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogil</surname><given-names>J. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Pain genetics: past, present and future.</article-title>
<source/><italic>Trends Genet.</italic>
<volume>28</volume>
<fpage>258</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2012.02.004</pub-id>
<pub-id pub-id-type="pmid">22464640</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustafa</surname><given-names>A. E.</given-names></name><name><surname>Faquih</surname><given-names>T.</given-names></name><name><surname>Baz</surname><given-names>B.</given-names></name><name><surname>Kattan</surname><given-names>R.</given-names></name><name><surname>Al-Issa</surname><given-names>A.</given-names></name><name><surname>Tahir</surname><given-names>A. I.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Validation of ion torrent(TM) inherited disease panel with the PGM(TM) sequencing platform for rapid and comprehensive mutation detection.</article-title>
<source/><italic>Genes (Basel.)</italic>
<volume>9</volume>
<issue>267</issue>. <pub-id pub-id-type="doi">10.3390/genes9050267</pub-id>
<pub-id pub-id-type="pmid">29789446</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nackley</surname><given-names>A. G.</given-names></name><name><surname>Shabalina</surname><given-names>S. A.</given-names></name><name><surname>Tchivileva</surname><given-names>I. E.</given-names></name><name><surname>Satterfield</surname><given-names>K.</given-names></name><name><surname>Korchynskyi</surname><given-names>O.</given-names></name><name><surname>Makarov</surname><given-names>S. S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.</article-title>
<source/><italic>Science</italic>
<volume>314</volume>
<fpage>1930</fpage>–<lpage>1933</lpage>. <pub-id pub-id-type="doi">10.1126/science.1131262</pub-id>
<pub-id pub-id-type="pmid">17185601</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naumov</surname><given-names>D. E.</given-names></name><name><surname>Perelman</surname><given-names>J. M.</given-names></name><name><surname>Kolosov</surname><given-names>V. P.</given-names></name><name><surname>Potapova</surname><given-names>T. A.</given-names></name><name><surname>Maksimov</surname><given-names>V. N.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Transient receptor potential melastatin 8 gene polymorphism is associated with cold-induced airway hyperresponsiveness in bronchial asthma.</article-title>
<source/><italic>Respirology</italic>
<volume>20</volume>
<fpage>1192</fpage>–<lpage>1197</lpage>. <pub-id pub-id-type="doi">10.1111/resp.12605</pub-id>
<pub-id pub-id-type="pmid">26272603</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemeth</surname><given-names>E.</given-names></name><name><surname>Rivera</surname><given-names>S.</given-names></name><name><surname>Gabayan</surname><given-names>V.</given-names></name><name><surname>Keller</surname><given-names>C.</given-names></name><name><surname>Taudorf</surname><given-names>S.</given-names></name><name><surname>Pedersen</surname><given-names>B. K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>113</volume>
<fpage>1271</fpage>–<lpage>1276</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200420945</pub-id>
<pub-id pub-id-type="pmid">15124018</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholl</surname><given-names>B. I.</given-names></name><name><surname>Holliday</surname><given-names>K. L.</given-names></name><name><surname>Macfarlane</surname><given-names>G. J.</given-names></name><name><surname>Thomson</surname><given-names>W.</given-names></name><name><surname>Davies</surname><given-names>K. A.</given-names></name><name><surname>O’neill</surname><given-names>T. W.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts.</article-title>
<source/><italic>Arthritis Rheum.</italic>
<volume>63</volume>
<fpage>810</fpage>–<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1002/art.30185</pub-id>
<pub-id pub-id-type="pmid">21305503</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissenbaum</surname><given-names>J.</given-names></name><name><surname>Devor</surname><given-names>M.</given-names></name><name><surname>Seltzer</surname><given-names>Z.</given-names></name><name><surname>Gebauer</surname><given-names>M.</given-names></name><name><surname>Michaelis</surname><given-names>M.</given-names></name><name><surname>Tal</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.</article-title>
<source/><italic>Genome Res.</italic>
<volume>20</volume>
<fpage>1180</fpage>–<lpage>1190</lpage>. <pub-id pub-id-type="doi">10.1101/gr.104976.110</pub-id>
<pub-id pub-id-type="pmid">20688780</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nöthen</surname><given-names>M. M.</given-names></name><name><surname>Cichon</surname><given-names>S.</given-names></name><name><surname>Hemmer</surname><given-names>S.</given-names></name><name><surname>Hebebrand</surname><given-names>J.</given-names></name><name><surname>Remschmidt</surname><given-names>H.</given-names></name><name><surname>Lehmkuhl</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>3</volume>
<fpage>2207</fpage>–<lpage>2212</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/3.12.2207</pub-id>
<pub-id pub-id-type="pmid">7881421</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obata</surname><given-names>K.</given-names></name><name><surname>Noguchi</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>BDNF in sensory neurons and chronic pain.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>55</volume>
<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2006.01.005</pub-id>
<pub-id pub-id-type="pmid">16516994</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oertel</surname><given-names>B. G.</given-names></name><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Roskam</surname><given-names>B.</given-names></name><name><surname>Kettner</surname><given-names>M.</given-names></name><name><surname>Hackmann</surname><given-names>N.</given-names></name><name><surname>Ferreiros</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetic-epigenetic interaction modulates mu-opioid receptor regulation.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>21</volume>
<fpage>4751</fpage>–<lpage>4760</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds314</pub-id>
<pub-id pub-id-type="pmid">22875838</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oertel</surname><given-names>B. G.</given-names></name><name><surname>Schmidt</surname><given-names>R.</given-names></name><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>The mu-opioid receptor gene polymorphism 118A&gt;G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers.</article-title>
<source/><italic>Pharmacogenet. Genom.</italic>
<volume>16</volume>
<fpage>625</fpage>–<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1097/01.fpc.0000220566.90466.a2</pub-id>
<pub-id pub-id-type="pmid">16906017</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Offenbaecher</surname><given-names>M.</given-names></name><name><surname>Bondy</surname><given-names>B.</given-names></name><name><surname>De Jonge</surname><given-names>S.</given-names></name><name><surname>Glatzeder</surname><given-names>K.</given-names></name><name><surname>Kruger</surname><given-names>M.</given-names></name><name><surname>Schoeps</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region.</article-title>
<source/><italic>Arthritis Rheum.</italic>
<volume>42</volume>
<fpage>2482</fpage>–<lpage>2488</lpage>. <pub-id pub-id-type="doi">10.1002/1529-0131(199911)42:11&lt;2482::AID-ANR27&gt;3.0.CO;2-B</pub-id>
<pub-id pub-id-type="pmid">10555044</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaya</surname><given-names>T.</given-names></name><name><surname>Ishii</surname><given-names>M.</given-names></name><name><surname>Katoh</surname><given-names>H.</given-names></name><name><surname>Shimizu</surname><given-names>S.</given-names></name><name><surname>Kasai</surname><given-names>H.</given-names></name><name><surname>Kawamura</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Predictive index for the onset of medication overuse headache in migraine patients.</article-title>
<source/><italic>Neurol. Sci.</italic>
<volume>34</volume>
<fpage>85</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-012-0955-7</pub-id>
<pub-id pub-id-type="pmid">22290307</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onojjighofia</surname><given-names>T.</given-names></name><name><surname>Meshkin</surname><given-names>B.</given-names></name><name><surname>Nguyen</surname><given-names>S. V.</given-names></name><name><surname>Schwartz</surname><given-names>D.</given-names></name><name><surname>Akindele</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Perception of analgesia in narcotic users with chronic pain: a multi-center cross-sectional study comparing genotype to pain VAS (P.A<italic>.I.N</italic>. Study).</article-title>
<source/><italic>Neurology</italic>
<volume>82</volume>:<issue>E39</issue>.</mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyanguren-Desez</surname><given-names>O.</given-names></name><name><surname>Rodríguez-Antigüedad</surname><given-names>A.</given-names></name><name><surname>Villoslada</surname><given-names>P.</given-names></name><name><surname>Domercq</surname><given-names>M.</given-names></name><name><surname>Alberdi</surname><given-names>E.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Gain-of-function of P2X7 receptor gene variants in multiple sclerosis.</article-title>
<source/><italic>Cell Calcium</italic>
<volume>50</volume>
<fpage>468</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2011.08.002</pub-id>
<pub-id pub-id-type="pmid">21906809</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmirotta</surname><given-names>R.</given-names></name><name><surname>Barbanti</surname><given-names>P.</given-names></name><name><surname>De Marchis</surname><given-names>M. L.</given-names></name><name><surname>Egeo</surname><given-names>G.</given-names></name><name><surname>Aurilia</surname><given-names>C.</given-names></name><name><surname>Fofi</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>22</volume>
<fpage>275</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2014.6069</pub-id>
<pub-id pub-id-type="pmid">25295643</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J. J.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>M. A.</given-names></name><name><surname>Back</surname><given-names>S. K.</given-names></name><name><surname>Hong</surname><given-names>S. K.</given-names></name><name><surname>Na</surname><given-names>H. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Induction of total insensitivity to capsaicin and hypersensitivity to garlic extract in human by decreased expression of TRPV1.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>411</volume>
<fpage>87</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2006.10.046</pub-id>
<pub-id pub-id-type="pmid">17110039</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiro</surname><given-names>A. M.</given-names></name><name><surname>Planelles</surname><given-names>B.</given-names></name><name><surname>Juhasz</surname><given-names>G.</given-names></name><name><surname>Bagdy</surname><given-names>G.</given-names></name><name><surname>Libert</surname><given-names>F.</given-names></name><name><surname>Eschalier</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Pharmacogenomics in pain treatment.</article-title>
<source/><italic>Drug Metab. Pers Ther.</italic>
<volume>31</volume>
<fpage>131</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1515/dmpt-2016-0005</pub-id>
<pub-id pub-id-type="pmid">27662648</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelletier</surname><given-names>C.</given-names></name><name><surname>Weidhaas</surname><given-names>J. B.</given-names></name></person-group> (<year>2010</year>). <article-title>MicroRNA binding site polymorphisms as biomarkers of cancer risk.</article-title>
<source/><italic>Expert. Rev. Mol. Diagn.</italic>
<volume>10</volume>
<fpage>817</fpage>–<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1586/erm.10.59</pub-id>
<pub-id pub-id-type="pmid">20843204</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrenko</surname><given-names>A. B.</given-names></name><name><surname>Yamakura</surname><given-names>T.</given-names></name><name><surname>Baba</surname><given-names>H.</given-names></name><name><surname>Shimoji</surname><given-names>K.</given-names></name></person-group> (<year>2003</year>). <article-title>The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review.</article-title>
<source/><italic>Anesth. Analg.</italic>
<volume>97</volume>
<fpage>1108</fpage>–<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1213/01.ANE.0000081061.12235.55</pub-id><pub-id pub-id-type="pmid">14500166</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potapova</surname><given-names>T. A.</given-names></name><name><surname>Babenko</surname><given-names>V. N.</given-names></name><name><surname>Kobzev</surname><given-names>V. F.</given-names></name><name><surname>Romashchenko</surname><given-names>A. G.</given-names></name><name><surname>Maksimov</surname><given-names>V. N.</given-names></name><name><surname>Voevoda</surname><given-names>M. I.</given-names></name></person-group> (<year>2014</year>). <article-title>Associations of cold receptor TRPM8 gene single nucleotide polymorphism with blood lipids and anthropometric parameters in Russian population.</article-title>
<source/><italic>Bull. Exp. Biol. Med.</italic>
<volume>157</volume>
<fpage>757</fpage>–<lpage>761</lpage>. <pub-id pub-id-type="doi">10.1007/s10517-014-2660-4</pub-id>
<pub-id pub-id-type="pmid">25348565</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potvin</surname><given-names>S.</given-names></name><name><surname>Larouche</surname><given-names>A.</given-names></name><name><surname>Normand</surname><given-names>E.</given-names></name><name><surname>De Souza</surname><given-names>J. B.</given-names></name><name><surname>Gaumond</surname><given-names>I.</given-names></name><name><surname>Grignon</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.</article-title>
<source/><italic>J. Pain</italic>
<volume>10</volume>
<fpage>969</fpage>–<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2009.03.013</pub-id>
<pub-id pub-id-type="pmid">19464960</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>H. C.</given-names></name><name><surname>Steiner</surname><given-names>J. A.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Blakely</surname><given-names>R. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Enhanced activity of human serotonin transporter variants associated with autism.</article-title>
<source/><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci.</italic>
<volume>364</volume>
<fpage>163</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2008.0143</pub-id>
<pub-id pub-id-type="pmid">18957375</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="book"><collab>R Development Core Team</collab> (<year>2008</year>). <source/><italic>R: A Language and Environment for Statistical Computing.</italic>
<publisher-loc>Vienna</publisher-loc>: <publisher-name>R Development Core Team</publisher-name>.</mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakvag</surname><given-names>T. T.</given-names></name><name><surname>Klepstad</surname><given-names>P.</given-names></name><name><surname>Baar</surname><given-names>C.</given-names></name><name><surname>Kvam</surname><given-names>T. M.</given-names></name><name><surname>Dale</surname><given-names>O.</given-names></name><name><surname>Kaasa</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.</article-title>
<source/><italic>Pain</italic>
<volume>116</volume>
<fpage>73</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2005.03.032</pub-id>
<pub-id pub-id-type="pmid">15927391</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimann</surname><given-names>F.</given-names></name><name><surname>Cox</surname><given-names>J. J.</given-names></name><name><surname>Belfer</surname><given-names>I.</given-names></name><name><surname>Diatchenko</surname><given-names>L.</given-names></name><name><surname>Zaykin</surname><given-names>D. V.</given-names></name><name><surname>Mchale</surname><given-names>D. P.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Pain perception is altered by a nucleotide polymorphism in SCN9A.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>5148</fpage>–<lpage>5153</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0913181107</pub-id>
<pub-id pub-id-type="pmid">20212137</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes-Gibby</surname><given-names>C. C.</given-names></name><name><surname>Shete</surname><given-names>S.</given-names></name><name><surname>Rakvag</surname><given-names>T.</given-names></name><name><surname>Bhat</surname><given-names>S. V.</given-names></name><name><surname>Skorpen</surname><given-names>F.</given-names></name><name><surname>Bruera</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.</article-title>
<source/><italic>Pain</italic>
<volume>130</volume>
<fpage>25</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2006.10.023</pub-id>
<pub-id pub-id-type="pmid">17156920</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro-Dasilva</surname><given-names>M. C.</given-names></name><name><surname>Peres Line</surname><given-names>S. R.</given-names></name><name><surname>Leme Godoy</surname></name><name><surname>Dos Santos</surname><given-names>M. C.</given-names></name><name><surname>Arthuri</surname><given-names>M. T.</given-names></name><name><surname>Hou</surname><given-names>W.</given-names></name></person-group><etal></etal> (<year>2009</year>). <article-title>Estrogen receptor-alpha polymorphisms and predisposition to TMJ disorder.</article-title>
<source/><italic>J. Pain</italic>
<volume>10</volume>
<fpage>527</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2008.11.012</pub-id>
<pub-id pub-id-type="pmid">19411060</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>P.</given-names></name><name><surname>De Marco</surname><given-names>G.</given-names></name><name><surname>Furriol</surname><given-names>J.</given-names></name><name><surname>Mansego</surname><given-names>M. L.</given-names></name><name><surname>Pineda-Alonso</surname><given-names>M.</given-names></name><name><surname>Gonzalez-Neira</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Oxidative stress in susceptibility to breast cancer: study in Spanish population.</article-title>
<source/><italic>BMC Cancer</italic>
<volume>14</volume>:<issue>861</issue>. <pub-id pub-id-type="doi">10.1186/1471-2407-14-861</pub-id>
<pub-id pub-id-type="pmid">25416100</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Root</surname><given-names>T. L.</given-names></name><name><surname>Szatkiewicz</surname><given-names>J. P.</given-names></name><name><surname>Jonassaint</surname><given-names>C. R.</given-names></name><name><surname>Thornton</surname><given-names>L. M.</given-names></name><name><surname>Pinheiro</surname><given-names>A. P.</given-names></name><name><surname>Strober</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Association of candidate genes with phenotypic traits relevant to anorexia nervosa.</article-title>
<source/><italic>Eur. Eat Disord. Rev.</italic>
<volume>19</volume>
<fpage>487</fpage>–<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1002/erv.1138</pub-id>
<pub-id pub-id-type="pmid">21780254</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname><given-names>D. W.</given-names></name><name><surname>Ossipov</surname><given-names>M. H.</given-names></name><name><surname>Rossomando</surname><given-names>A.</given-names></name><name><surname>Silvian</surname><given-names>L.</given-names></name><name><surname>Porreca</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>New approaches for the treatment of pain: the GDNF family of neurotrophic growth factors.</article-title>
<source/><italic>Curr. Top. Med. Chem.</italic>
<volume>5</volume>
<fpage>577</fpage>–<lpage>583</lpage>. <pub-id pub-id-type="doi">10.2174/1568026054367593</pub-id>
<pub-id pub-id-type="pmid">16022680</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanger</surname><given-names>F.</given-names></name><name><surname>Coulson</surname><given-names>A. R.</given-names></name></person-group> (<year>1975</year>). <article-title>A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.</article-title>
<source/><italic>J. Mol. Biol.</italic>
<volume>94</volume>
<fpage>441</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1016/0022-2836(75)90213-2</pub-id>
<pub-id pub-id-type="pmid">1100841</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanger</surname><given-names>F.</given-names></name><name><surname>Nicklen</surname><given-names>S.</given-names></name><name><surname>Coulson</surname><given-names>A. R.</given-names></name></person-group> (<year>1977</year>). <article-title>DNA sequencing with chain-terminating inhibitors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>74</volume>
<fpage>5463</fpage>–<lpage>5467</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.74.12.5463</pub-id><pub-id pub-id-type="pmid">271968</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Ohashi</surname><given-names>J.</given-names></name><name><surname>Tsuchiya</surname><given-names>N.</given-names></name><name><surname>Kashiwase</surname><given-names>K.</given-names></name><name><surname>Ishikawa</surname><given-names>Y.</given-names></name><name><surname>Arita</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Association of HLA-A<sup>∗</sup>3303-B<sup>∗</sup>4403-DRB1<sup>∗</sup>1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population.</article-title>
<source/><italic>Genes Immun.</italic>
<volume>3</volume>
<fpage>477</fpage>–<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1038/sj.gene.6363890</pub-id>
<pub-id pub-id-type="pmid">12486606</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savas</surname><given-names>S.</given-names></name><name><surname>Schmidt</surname><given-names>S.</given-names></name><name><surname>Jarjanazi</surname><given-names>H.</given-names></name><name><surname>Ozcelik</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations.</article-title>
<source/><italic>Hum. Genomics</italic>
<volume>2</volume>
<fpage>287</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1186/1479-7364-2-5-287</pub-id>
<pub-id pub-id-type="pmid">16595073</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schleinitz</surname><given-names>D.</given-names></name><name><surname>Carmienke</surname><given-names>S.</given-names></name><name><surname>Böttcher</surname><given-names>Y.</given-names></name><name><surname>Tönjes</surname><given-names>A.</given-names></name><name><surname>Berndt</surname><given-names>J.</given-names></name><name><surname>Klöting</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity.</article-title>
<source/><italic>Pharmacogenomics</italic>
<volume>11</volume>
<fpage>693</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.2217/pgs.10.42</pub-id>
<pub-id pub-id-type="pmid">20415562</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>S.</given-names></name><name><surname>Hauser</surname><given-names>M. A.</given-names></name><name><surname>Scott</surname><given-names>W. K.</given-names></name><name><surname>Postel</surname><given-names>E. A.</given-names></name><name><surname>Agarwal</surname><given-names>A.</given-names></name><name><surname>Gallins</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>78</volume>
<fpage>852</fpage>–<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1086/503822</pub-id>
<pub-id pub-id-type="pmid">16642439</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schott</surname><given-names>K.</given-names></name><name><surname>Gutlich</surname><given-names>M.</given-names></name><name><surname>Ziegler</surname><given-names>I.</given-names></name></person-group> (<year>1993</year>). <article-title>Induction of GTP-cyclohydrolase I mRNA expression by lectin activation and interferon-gamma treatment in human cells associated with the immune response.</article-title>
<source/><italic>J. Cell. Physiol.</italic>
<volume>156</volume>
<fpage>12</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.1041560103</pub-id>
<pub-id pub-id-type="pmid">8314853</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurks</surname><given-names>M.</given-names></name><name><surname>Kurth</surname><given-names>T.</given-names></name><name><surname>Buring</surname><given-names>J. E.</given-names></name><name><surname>Zee</surname><given-names>R. Y.</given-names></name></person-group> (<year>2009</year>). <article-title>A candidate gene association study of 77 polymorphisms in migraine.</article-title>
<source/><italic>J. Pain</italic>
<volume>10</volume>
<fpage>759</fpage>–<lpage>766</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2009.01.326</pub-id>
<pub-id pub-id-type="pmid">19559392</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schürks</surname><given-names>M.</given-names></name><name><surname>Rist</surname><given-names>P. M.</given-names></name><name><surname>Kurth</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis.</article-title>
<source/><italic>Cephalalgia</italic>
<volume>30</volume>
<fpage>1306</fpage>–<lpage>1328</lpage>. <pub-id pub-id-type="doi">10.1177/0333102410364155</pub-id>
<pub-id pub-id-type="pmid">20959426</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schütz</surname><given-names>M.</given-names></name><name><surname>Oertel</surname><given-names>B. G.</given-names></name><name><surname>Heimann</surname><given-names>D.</given-names></name><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Walter</surname><given-names>C.</given-names></name><name><surname>Dimova</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Consequences of a human TRPA1 genetic variant on the perception of nociceptive and olfactory stimuli.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e95592</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0095592</pub-id>
<pub-id pub-id-type="pmid">24752136</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>E. S.</given-names></name><name><surname>Kim</surname><given-names>H. Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>I.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name><name><surname>Chung</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Persistent pain is dependent on spinal mitochondrial antioxidant levels.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>159</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3792-08.2009</pub-id><pub-id pub-id-type="pmid">19129394</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweinhardt</surname><given-names>P.</given-names></name><name><surname>Sauro</surname><given-names>K. M.</given-names></name><name><surname>Bushnell</surname><given-names>M. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Fibromyalgia: a disorder of the brain?</article-title>
<source/><italic>Neuroscientist</italic>
<volume>14</volume>
<fpage>415</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1177/1073858407312521</pub-id>
<pub-id pub-id-type="pmid">18270311</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serý</surname><given-names>O.</given-names></name><name><surname>Prikryl</surname><given-names>R.</given-names></name><name><surname>Castulík</surname><given-names>L.</given-names></name><name><surname>St’astný</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>A118G polymorphism of OPRM1 gene is associated with schizophrenia.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>41</volume>
<fpage>219</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-010-9327-z</pub-id>
<pub-id pub-id-type="pmid">20112002</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>N. D.</given-names></name><name><surname>Shah</surname><given-names>P. S.</given-names></name><name><surname>Panchal</surname><given-names>Y. Y.</given-names></name><name><surname>Katudia</surname><given-names>K. H.</given-names></name><name><surname>Khatri</surname><given-names>N. B.</given-names></name><name><surname>Ray</surname><given-names>H. S. P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients.</article-title>
<source/><italic>Appl. Clin. Genet.</italic>
<volume>11</volume>
<fpage>59</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.2147/TACG.S155955</pub-id>
<pub-id pub-id-type="pmid">29785135</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherry</surname><given-names>S. T.</given-names></name><name><surname>Ward</surname><given-names>M. H.</given-names></name><name><surname>Kholodov</surname><given-names>M.</given-names></name><name><surname>Baker</surname><given-names>J.</given-names></name><name><surname>Phan</surname><given-names>L.</given-names></name><name><surname>Smigielski</surname><given-names>E. M.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>dbSNP: the NCBI database of genetic variation.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>29</volume>
<fpage>308</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id><pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Badner</surname><given-names>J. A.</given-names></name><name><surname>Hattori</surname><given-names>E.</given-names></name><name><surname>Potash</surname><given-names>J. B.</given-names></name><name><surname>Willour</surname><given-names>V. L.</given-names></name><name><surname>Mcmahon</surname><given-names>F. J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Neurotransmission and bipolar disorder: a systematic family-based association study.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>147B</volume>
<fpage>1270</fpage>–<lpage>1277</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30769</pub-id>
<pub-id pub-id-type="pmid">18444252</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>T.-J. S.</given-names></name><name><surname>Liu</surname><given-names>S.-X. L.</given-names></name><name><surname>Hammarberg</surname><given-names>H.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>Z.-Q. D.</given-names></name><name><surname>Hökfelt</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Phospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>20004</fpage>–<lpage>20008</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0810899105</pub-id>
<pub-id pub-id-type="pmid">19066214</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoskes</surname><given-names>D. A.</given-names></name><name><surname>Albakri</surname><given-names>Q.</given-names></name><name><surname>Thomas</surname><given-names>K.</given-names></name><name><surname>Cook</surname><given-names>D.</given-names></name></person-group> (<year>2002</year>). <article-title>Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response.</article-title>
<source/><italic>J. Urol.</italic>
<volume>168</volume>
<fpage>331</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(05)64916-6</pub-id>
<pub-id pub-id-type="pmid">12050565</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siqueira</surname><given-names>E. C. D.</given-names></name><name><surname>De Sousa</surname><given-names>S. F.</given-names></name><name><surname>França</surname><given-names>J. A.</given-names></name><name><surname>Diniz</surname><given-names>M. G.</given-names></name><name><surname>Pereira</surname><given-names>T. D. S. F.</given-names></name><name><surname>Moreira</surname><given-names>R. G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Targeted next-generation sequencing of glandular odontogenic cyst: a preliminary study.</article-title>
<source/><italic>Oral. Surg. Oral Med. Oral. Pathol. Oral Radiol.</italic>
<volume>124</volume>
<fpage>490</fpage>–<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1016/j.oooo.2017.07.001</pub-id>
<pub-id pub-id-type="pmid">28866361</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarke</surname><given-names>C.</given-names></name><name><surname>Kirchhof</surname><given-names>A.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Comprehensive mu-opioid-receptor genotyping by pyrosequencing.</article-title>
<source/><italic>Clin. Chem.</italic>
<volume>50</volume>
<fpage>640</fpage>–<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1373/clinchem.2003.027607</pub-id>
<pub-id pub-id-type="pmid">14981031</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarke</surname><given-names>C.</given-names></name><name><surname>Kirchhof</surname><given-names>A.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.</article-title>
<source/><italic>Eur. J. Clin. Pharmacol.</italic>
<volume>61</volume>
<fpage>887</fpage>–<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1007/s00228-005-0029-3</pub-id>
<pub-id pub-id-type="pmid">16307269</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sluka</surname><given-names>K. A.</given-names></name><name><surname>Audette</surname><given-names>K. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Activation of protein kinase C in the spinal cord produces mechanical hyperalgesia by activating glutamate receptors, but does not mediate chronic muscle-induced hyperalgesia.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>2</volume>:<issue>13</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-2-13</pub-id>
<pub-id pub-id-type="pmid">16584564</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>F. L.</given-names></name><name><surname>Fujimori</surname><given-names>K.</given-names></name><name><surname>Lowe</surname><given-names>J.</given-names></name><name><surname>Welch</surname><given-names>S. P.</given-names></name></person-group> (<year>1998</year>). <article-title>Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>60</volume>
<fpage>183</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-3057(97)00583-2</pub-id>
<pub-id pub-id-type="pmid">9610941</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snider</surname><given-names>W. D.</given-names></name><name><surname>McMahon</surname><given-names>S. B.</given-names></name></person-group> (<year>1998</year>). <article-title>Tackling pain at the source: new ideas about nociceptors.</article-title>
<source/><italic>Neuron</italic>
<volume>20</volume>
<fpage>629</fpage>–<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)81003-X</pub-id>
<pub-id pub-id-type="pmid">9581756</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solus</surname><given-names>J. F.</given-names></name><name><surname>Chung</surname><given-names>C. P.</given-names></name><name><surname>Oeser</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Rho</surname><given-names>Y. H.</given-names></name><name><surname>Bradley</surname><given-names>K. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.</article-title>
<source/><italic>Clin. Rheumatol.</italic>
<volume>34</volume>
<fpage>1375</fpage>–<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-015-2881-6</pub-id>
<pub-id pub-id-type="pmid">25652333</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somogyi</surname><given-names>A. A.</given-names></name><name><surname>Coller</surname><given-names>J. K.</given-names></name><name><surname>Barratt</surname><given-names>D. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Pharmacogenetics of opioid response.</article-title>
<source/><italic>Clin. Pharmacol. Ther.</italic>
<volume>97</volume>
<fpage>125</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1002/cpt.23</pub-id>
<pub-id pub-id-type="pmid">25670515</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somogyi</surname><given-names>A. A.</given-names></name><name><surname>Sia</surname><given-names>A. T.</given-names></name><name><surname>Tan</surname><given-names>E.-C.</given-names></name><name><surname>Coller</surname><given-names>J. K.</given-names></name><name><surname>Hutchinson</surname><given-names>M. R.</given-names></name><name><surname>Barratt</surname><given-names>D. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Ethnicity-dependent influence of innate immune genetic markers on morphine PCA requirements and adverse effects in postoperative pain.</article-title>
<source/><italic>Pain</italic>
<volume>157</volume>
<fpage>2458</fpage>–<lpage>2466</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000661</pub-id>
<pub-id pub-id-type="pmid">27649267</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonoda</surname><given-names>T.</given-names></name><name><surname>Takada</surname><given-names>J.</given-names></name><name><surname>Iba</surname><given-names>K.</given-names></name><name><surname>Asakura</surname><given-names>S.</given-names></name><name><surname>Yamashita</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Interaction between ESRα polymorphisms and environmental factors in osteoporosis.</article-title>
<source/><italic>J. Orthop. Res.</italic>
<volume>30</volume>
<fpage>1529</fpage>–<lpage>1534</lpage>. <pub-id pub-id-type="doi">10.1002/jor.22083</pub-id>
<pub-id pub-id-type="pmid">22328322</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorge</surname><given-names>R. E.</given-names></name><name><surname>Trang</surname><given-names>T.</given-names></name><name><surname>Dorfman</surname><given-names>R.</given-names></name><name><surname>Smith</surname><given-names>S. B.</given-names></name><name><surname>Beggs</surname><given-names>S.</given-names></name><name><surname>Ritchie</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>18</volume>
<fpage>595</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2710</pub-id>
<pub-id pub-id-type="pmid">22447075</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>K.</given-names></name><name><surname>Cooper</surname><given-names>B. A.</given-names></name><name><surname>West</surname><given-names>C.</given-names></name><name><surname>Paul</surname><given-names>S. M.</given-names></name><name><surname>Baggott</surname><given-names>C. R.</given-names></name><name><surname>Merriman</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery.</article-title>
<source/><italic>J. Pain</italic>
<volume>15</volume>
<fpage>169</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2013.09.015</pub-id>
<pub-id pub-id-type="pmid">24411993</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugaya</surname><given-names>K.</given-names></name><name><surname>Nishijima</surname><given-names>S.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Miyazato</surname><given-names>M.</given-names></name><name><surname>Hatano</surname><given-names>T.</given-names></name><name><surname>Ogawa</surname><given-names>Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular analysis of adrenergic receptor genes and interleukin-4/interleukin-4 receptor genes in patients with interstitial cystitis.</article-title>
<source/><italic>J. Urol.</italic>
<volume>168</volume>
<fpage>2668</fpage>–<lpage>2671</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(05)64241-3</pub-id>
<pub-id pub-id-type="pmid">12442007</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.-G.</given-names></name><name><surname>Gracias</surname><given-names>N. G.</given-names></name><name><surname>Drobish</surname><given-names>J. K.</given-names></name><name><surname>Vasko</surname><given-names>M. R.</given-names></name><name><surname>Gereau</surname><given-names>R. W.</given-names></name><name><surname>Chen</surname><given-names>Z.-F.</given-names></name></person-group> (<year>2009</year>). <article-title>The c-kit signaling pathway is involved in the development of persistent pain.</article-title>
<source/><italic>Pain</italic>
<volume>144</volume>
<fpage>178</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2009.04.011</pub-id>
<pub-id pub-id-type="pmid">19443120</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegeder</surname><given-names>I.</given-names></name><name><surname>Costigan</surname><given-names>M.</given-names></name><name><surname>Griffin</surname><given-names>R. S.</given-names></name><name><surname>Abele</surname><given-names>A.</given-names></name><name><surname>Belfer</surname><given-names>I.</given-names></name><name><surname>Schmidt</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>12</volume>
<fpage>1269</fpage>–<lpage>1277</lpage>. <pub-id pub-id-type="doi">10.1038/nm1490</pub-id>
<pub-id pub-id-type="pmid">17057711</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thuault</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>A peripheral messenger for chronic pain.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>19</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1038/nn.4217</pub-id>
<pub-id pub-id-type="pmid">26713743</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thulasiraman</surname><given-names>K.</given-names></name><name><surname>Swamy</surname><given-names>M. N. S.</given-names></name></person-group> (<year>1992</year>). <source/><italic>Graphs : Theory and Algorithms.</italic>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Wiley</publisher-name>
<pub-id pub-id-type="doi">10.1002/9781118033104</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>W.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Garcia-Elias</surname><given-names>A.</given-names></name><name><surname>Fernández-Fernández</surname><given-names>J. M.</given-names></name><name><surname>Vicente</surname><given-names>R.</given-names></name><name><surname>Kramer</surname><given-names>P. L.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>14034</fpage>–<lpage>14039</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0904084106</pub-id>
<pub-id pub-id-type="pmid">19666518</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S.-J.</given-names></name><name><surname>Hong</surname><given-names>C.-J.</given-names></name><name><surname>Cheng</surname><given-names>C.-Y.</given-names></name><name><surname>Liao</surname><given-names>D.-L.</given-names></name><name><surname>Liou</surname><given-names>Y.-J.</given-names></name></person-group> (<year>2007</year>). <article-title>Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia.</article-title>
<source/><italic>J. Neural Transm. (Vienna)</italic>
<volume>114</volume>
<fpage>423</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-006-0587-2</pub-id>
<pub-id pub-id-type="pmid">17093888</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsantoulas</surname><given-names>C.</given-names></name><name><surname>Mooney</surname><given-names>E. R.</given-names></name><name><surname>Mcnaughton</surname><given-names>P. A.</given-names></name></person-group> (<year>2016</year>). <article-title>HCN2 ion channels: basic science opens up possibilities for therapeutic intervention in neuropathic pain.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>473</volume>
<fpage>2717</fpage>–<lpage>2736</lpage>. <pub-id pub-id-type="doi">10.1042/BCJ20160287</pub-id>
<pub-id pub-id-type="pmid">27621481</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tulah</surname><given-names>A. S.</given-names></name><name><surname>Beghe</surname><given-names>B.</given-names></name><name><surname>Barton</surname><given-names>S. J.</given-names></name><name><surname>Holloway</surname><given-names>J. W.</given-names></name><name><surname>Sayers</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>Leukotriene B4 receptor locus gene characterisation and association studies in asthma.</article-title>
<source/><italic>BMC Med. Genet.</italic>
<volume>13</volume>:<issue>110</issue>. <pub-id pub-id-type="doi">10.1186/1471-2350-13-110</pub-id>
<pub-id pub-id-type="pmid">23167751</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ultsch</surname><given-names>A.</given-names></name><name><surname>Kringel</surname><given-names>D.</given-names></name><name><surname>Kalso</surname><given-names>E.</given-names></name><name><surname>Mogil</surname><given-names>J. S.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>A data science approach to candidate gene selection of pain regarded as a process of learning and neural plasticity.</article-title>
<source/><italic>Pain</italic>
<volume>157</volume>
<fpage>2747</fpage>–<lpage>2757</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000694</pub-id>
<pub-id pub-id-type="pmid">27548044</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ursu</surname><given-names>D.</given-names></name><name><surname>Ebert</surname><given-names>P.</given-names></name><name><surname>Langron</surname><given-names>E.</given-names></name><name><surname>Ruble</surname><given-names>C.</given-names></name><name><surname>Munsie</surname><given-names>L.</given-names></name><name><surname>Zou</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.</article-title>
<source/><italic>Mol Pain</italic>
<volume>10</volume>:<issue>37</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-10-37</pub-id>
<pub-id pub-id-type="pmid">24934217</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaclavikova</surname><given-names>E.</given-names></name><name><surname>Dvorakova</surname><given-names>S.</given-names></name><name><surname>Skaba</surname><given-names>R.</given-names></name><name><surname>Pos</surname><given-names>L.</given-names></name><name><surname>Sykorova</surname><given-names>V.</given-names></name><name><surname>Halkova</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>RET variants and haplotype analysis in a cohort of Czech patients with Hirschsprung disease.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e98957</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0098957</pub-id>
<pub-id pub-id-type="pmid">24897126</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadakkan</surname><given-names>K. I.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ko</surname><given-names>S. W.</given-names></name><name><surname>Zastepa</surname><given-names>E.</given-names></name><name><surname>Petrovic</surname><given-names>M. J.</given-names></name><name><surname>Sluka</surname><given-names>K. A.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Genetic reduction of chronic muscle pain in mice lacking calcium/calmodulin-stimulated adenylyl yclases.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>2</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-2-7</pub-id>
<pub-id pub-id-type="pmid">16503978</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassalli</surname><given-names>P.</given-names></name></person-group> (<year>1992</year>). <article-title>The pathophysiology of tumor necrosis factors.</article-title>
<source/><italic>Annu. Rev. Immunol.</italic>
<volume>10</volume>
<fpage>411</fpage>–<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.iy.10.040192.002211</pub-id><pub-id pub-id-type="pmid">1590993</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>J.</given-names></name></person-group> (<year>1880</year>). <article-title>On the diagrammatic and mechanical representation of propositions and reasonings.</article-title>
<source/><italic>Dublin Philos. Mag. J. Sci.</italic>
<volume>9</volume>
<fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1080/14786448008626877</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venter</surname><given-names>J. C.</given-names></name><name><surname>Adams</surname><given-names>M. D.</given-names></name><name><surname>Myers</surname><given-names>E. W.</given-names></name><name><surname>Li</surname><given-names>P. W.</given-names></name><name><surname>Mural</surname><given-names>R. J.</given-names></name><name><surname>Sutton</surname><given-names>G. G.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>The sequence of the human genome.</article-title>
<source/><italic>Science</italic>
<volume>291</volume>
<fpage>1304</fpage>–<lpage>1351</lpage>. <pub-id pub-id-type="doi">10.1126/science.1058040</pub-id>
<pub-id pub-id-type="pmid">11181995</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>K.</given-names></name><name><surname>Bowes</surname><given-names>M.</given-names></name><name><surname>Panesar</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>A.</given-names></name><name><surname>Gentry</surname><given-names>C.</given-names></name><name><surname>Kesingland</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>40</volume>
<fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0028-3908(00)00113-1</pub-id>
<pub-id pub-id-type="pmid">11077065</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>C.</given-names></name><name><surname>Doehring</surname><given-names>A.</given-names></name><name><surname>Oertel</surname><given-names>B. G.</given-names></name><name><surname>Lötsch</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>μ-opioid receptor gene variant OPRM1 118 A&gt;G: a summary of its molecular and clinical consequences for pain.</article-title>
<source/><italic>Pharmacogenomics</italic>
<volume>14</volume>
<fpage>1915</fpage>–<lpage>1925</lpage>. <pub-id pub-id-type="doi">10.2217/pgs.13.187</pub-id>
<pub-id pub-id-type="pmid">24236490</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Pang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Glial cell-derived neurotrophic factor attenuates neuropathic pain in a mouse model of chronic constriction injury: possible involvement of E-cadherin/p120ctn signaling.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>54</volume>
<fpage>156</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-014-0266-y</pub-id>
<pub-id pub-id-type="pmid">24599758</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.-S.</given-names></name><name><surname>Song</surname><given-names>H.-B.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>J.-Q.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.</article-title>
<source/><italic>J. Huazhong Univ. Sci. Technolog. Med. Sci.</italic>
<volume>35</volume>
<fpage>752</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1007/s11596-015-1502-6</pub-id>
<pub-id pub-id-type="pmid">26489634</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wedrén</surname><given-names>S.</given-names></name><name><surname>Lovmar</surname><given-names>L.</given-names></name><name><surname>Humphreys</surname><given-names>K.</given-names></name><name><surname>Magnusson</surname><given-names>C.</given-names></name><name><surname>Melhus</surname><given-names>H.</given-names></name><name><surname>Syvänen</surname><given-names>A.-C.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Estrogen receptor alpha gene polymorphism and endometrial cancer risk–a case-control study.</article-title>
<source/><italic>BMC Cancer</italic>
<volume>8</volume>:<issue>322</issue>. <pub-id pub-id-type="doi">10.1186/1471-2407-8-322</pub-id>
<pub-id pub-id-type="pmid">18990228</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><collab>Wellcome Trust Case Control and Consortium</collab>. (<year>2007</year>). <article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</article-title>
<source/><italic>Nature</italic>
<volume>447</volume>
<fpage>661</fpage>–<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1038/nature05911</pub-id>
<pub-id pub-id-type="pmid">17554300</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wise</surname><given-names>B. L.</given-names></name><name><surname>Demissie</surname><given-names>S.</given-names></name><name><surname>Cupples</surname><given-names>L. A.</given-names></name><name><surname>Felson</surname><given-names>D. T.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Shearman</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>The relationship of estrogen receptor-alpha and -beta genes with osteoarthritis of the hand.</article-title>
<source/><italic>J. Rheumatol.</italic>
<volume>36</volume>
<fpage>2772</fpage>–<lpage>2779</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.081208</pub-id>
<pub-id pub-id-type="pmid">19884274</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolters</surname><given-names>P. L.</given-names></name><name><surname>Burns</surname><given-names>K. M.</given-names></name><name><surname>Martin</surname><given-names>S.</given-names></name><name><surname>Baldwin</surname><given-names>A.</given-names></name><name><surname>Dombi</surname><given-names>E.</given-names></name><name><surname>Toledo-Tamula</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>167A</volume>
<fpage>2103</fpage>–<lpage>2113</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37123</pub-id>
<pub-id pub-id-type="pmid">25976979</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>J. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.</article-title>
<source/><italic>Menopause</italic>
<volume>22</volume>
<fpage>512</fpage>–<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1097/GME.0000000000000339</pub-id>
<pub-id pub-id-type="pmid">25268406</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Mitsuma</surname><given-names>N.</given-names></name><name><surname>Hattori</surname><given-names>N.</given-names></name><name><surname>Sobue</surname><given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>Pain-related differential expression of NGF, GDNF, IL-6, and their receptors in human vasculitic neuropathies.</article-title>
<source/><italic>Intern. Med.</italic>
<volume>42</volume>
<fpage>1100</fpage>–<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.2169/internalmedicine.42.1100</pub-id>
<pub-id pub-id-type="pmid">14686749</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>). <article-title>Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl-D-aspartate receptor subunit 2A.</article-title>
<source/><italic>Neurol. Sci.</italic>
<volume>35</volume>
<fpage>1365</fpage>–<lpage>1371</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-014-1713-9</pub-id>
<pub-id pub-id-type="pmid">24659417</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yücel</surname><given-names>Y.</given-names></name><name><surname>Coşkun</surname><given-names>S.</given-names></name><name><surname>Cengiz</surname><given-names>B.</given-names></name><name><surname>Özdemir</surname><given-names>H. H.</given-names></name><name><surname>Uzar</surname><given-names>E.</given-names></name><name><surname>Çim</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Association of polymorphisms within the serotonin receptor genes 5-HTR1A, 5-HTR1B, 5-HTR2A and 5-HTR2C and migraine susceptibility in a turkish population.</article-title>
<source/><italic>Clin. Psychopharmacol. Neurosci.</italic>
<volume>14</volume>
<fpage>250</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.9758/cpn.2016.14.3.250</pub-id>
<pub-id pub-id-type="pmid">27489378</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yucesoy</surname><given-names>B.</given-names></name><name><surname>Johnson</surname><given-names>V. J.</given-names></name><name><surname>Lummus</surname><given-names>Z. L.</given-names></name><name><surname>Kissling</surname><given-names>G. E.</given-names></name><name><surname>Fluharty</surname><given-names>K.</given-names></name><name><surname>Gautrin</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.</article-title>
<source/><italic>Toxicol. Sci.</italic>
<volume>129</volume>
<fpage>166</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfs183</pub-id>
<pub-id pub-id-type="pmid">22610343</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanette</surname><given-names>S. A.</given-names></name><name><surname>Dussan-Sarria</surname><given-names>J. A.</given-names></name><name><surname>Souza</surname><given-names>A.</given-names></name><name><surname>Deitos</surname><given-names>A.</given-names></name><name><surname>Torres</surname><given-names>I. L. S.</given-names></name><name><surname>Caumo</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>Higher serum S100B and BDNF levels are correlated with a lower pressure-pain threshold in fibromyalgia.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>10</volume>:<issue>46</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-10-46</pub-id>
<pub-id pub-id-type="pmid">25005881</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Rao</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Khandrika</surname><given-names>S.</given-names></name><name><surname>Das</surname><given-names>M.</given-names></name><name><surname>Vaingankar</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>117</volume>
<fpage>2658</fpage>–<lpage>2671</lpage>. <pub-id pub-id-type="doi">10.1172/JCI31093</pub-id>
<pub-id pub-id-type="pmid">17717598</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinn</surname><given-names>S.</given-names></name><name><surname>Sisignano</surname><given-names>M.</given-names></name><name><surname>Kern</surname><given-names>K.</given-names></name><name><surname>Pierre</surname><given-names>S.</given-names></name><name><surname>Tunaru</surname><given-names>S.</given-names></name><name><surname>Jordan</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>292</volume>
<fpage>6123</fpage>–<lpage>6134</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.769125</pub-id>
<pub-id pub-id-type="pmid">28242764</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zorina-Lichtenwalter</surname><given-names>K.</given-names></name><name><surname>Meloto</surname><given-names>C. B.</given-names></name><name><surname>Khoury</surname><given-names>S.</given-names></name><name><surname>Diatchenko</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic predictors of human chronic pain conditions.</article-title>
<source/><italic>Neuroscience</italic>
<volume>338</volume>
<fpage>36</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.04.041</pub-id>
<pub-id pub-id-type="pmid">27143481</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>